| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,929,968 -1.0% | USD 469.22-1.0% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,607,191-0.7% | USD 275.75-0.7% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 29,115,900-1.2% | USD 778.5-1.2% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,514,712-0.8% | USD 253.91-0.8% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,718,030 0.7% | USD 148.530.7% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,236,886-0.1% | USD 156.32-0.1% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,514,331-0.2% | USD 609.88-0.2% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,652,102-1.3% | USD 362.24-1.3% | |
| MRNA (Moderna Inc) | 206,666 | USD 8,578,706-9.1% | USD 41.51-9.1% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,019,323-2.3% | USD 12.51-2.3% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,563,801-0.7% | USD 48.08-0.7% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,514,7260.5% | USD 72.480.5% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,986,279-0.1% | USD 128.96-0.1% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 6,983,879-3.7% | USD 17.97-3.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,786,755-0.6% | USD 66.43-0.6% | |
| INSM (Insmed Inc) | 92,172 | USD 6,693,531-0.2% | USD 72.62-0.2% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,507,565-1.8% | USD 126.7-1.8% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,150,915-1.6% | USD 25.59-1.6% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,145,959-3.3% | USD 116.85-3.3% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,709,539-2.9% | USD 341.95-2.9% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,436,923-1.8% | USD 90.43-1.8% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,390,5420.2% | USD 35.230.2% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,818,796-1.1% | USD 12.09-1.1% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,706,769-2.2% | USD 83.11-2.2% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,449,750-9.7% | USD 187.5-9.7% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,245,0340.5% | USD 47.290.5% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,029,625-2.1% | USD 129.67-2.1% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 3,979,608-0.5% | USD 120.15-0.5% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,643,771-1.8% | USD 312.77-1.8% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,333,823 | USD 49.06 | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,240,5890.9% | USD 95.390.9% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,190,0590.1% | USD 50.550.1% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 3,017,911-0.8% | USD 38.26-0.8% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 2,975,928-1.0% | USD 92.96-1.0% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,946,486-1.6% | USD 29.04-1.6% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 2,872,0980.7% | USD 185.740.7% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,702,531-2.3% | USD 30.6-2.3% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,548,340-0.9% | USD 98.815-0.9% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,454,5941.0% | USD 57.171.0% | |
| RARE (Ultragenyx) | 49,439 | USD 2,426,961-0.5% | USD 49.09-0.5% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,417,3481.1% | USD 19.211.1% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,386,159-0.8% | USD 82.27-0.8% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,332,154-2.3% | USD 35.53-2.3% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,267,874-2.0% | USD 36.1-2.0% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,267,0730.8% | USD 28.940.8% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,255,168-1.1% | USD 34.64-1.1% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,244,537-2.3% | USD 48.68-2.3% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 2,056,2894.0% | USD 49.994.0% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,904,432-2.1% | USD 44.52-2.1% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,888,0400.6% | USD 57.740.6% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,873,142-1.9% | USD 24.49-1.9% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,765,7861.2% | USD 62.361.2% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,762,4810.5% | USD 42.980.5% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,743,137-3.3% | USD 4.64-3.3% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,715,2013.7% | USD 29.723.7% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,695,428-0.4% | USD 41.88-0.4% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,660,740-9.0% | USD 37.9-9.0% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,654,293-0.6% | USD 41.63-0.6% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,642,702-0.2% | USD 51.56-0.2% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,641,869-1.2% | USD 18.53-1.2% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,609,0803.1% | USD 10.133.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,593,4312.8% | USD 23.922.8% | |
| MRUS (Merus BV) | 36,597 | USD 1,571,475-1.8% | USD 42.94-1.8% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,560,5323.2% | USD 45.053.2% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,535,5862.1% | USD 57.562.1% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,526,991-1.9% | USD 39.45-1.9% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,525,797-1.2% | USD 28.33-1.2% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,485,196-2.6% | USD 29.46-2.6% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,401,723-5.4% | USD 46.02-5.4% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,398,297-3.9% | USD 8.59-3.9% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,376,539-1.2% | USD 46.92-1.2% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,335,019-1.2% | USD 66.31-1.2% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,333,2399.8% | USD 30.29.8% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,308,2782.7% | USD 41.62.7% | |
| GERN (Geron Corporation) | 324,203 | USD 1,293,5700.3% | USD 3.990.3% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,259,539-9.8% | USD 7.46-9.8% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,258,3700.1% | USD 27.770.1% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,173,6661.9% | USD 118.61.9% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,167,071-1.4% | USD 48.38-1.4% | |
| AMPH (Amphastar P) | 26,228 | USD 1,144,590-0.4% | USD 43.64-0.4% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,136,162-1.5% | USD 30.64-1.5% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,123,7121.8% | USD 44.11.8% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,108,956-0.1% | USD 34.695-0.1% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,094,5210.2% | USD 36.740.2% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,025,9160.0% | USD 50.650.0% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,022,751-6.1% | USD 21.15-6.1% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 1,013,131-1.3% | USD 14.965-1.3% | |
| MNKD (MannKind Corp) | 149,905 | USD 999,8660.2% | USD 6.670.2% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 998,833-2.3% | USD 32.71-2.3% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 911,7590.1% | USD 12.850.1% | |
| ARVN (Arvinas Inc) | 36,691 | USD 902,232-2.0% | USD 24.59-2.0% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 893,1722.6% | USD 7.932.6% | |
| XNCR (Xencor Inc) | 33,378 | USD 844,1300.4% | USD 25.290.4% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 816,0634.5% | USD 13.154.5% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 812,20114.3% | USD 10.4414.3% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 801,9010.7% | USD 14.720.7% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 790,481-0.1% | USD 18.75-0.1% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 783,9451.0% | USD 9.441.0% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 765,376-4.1% | USD 27.73-4.1% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 762,1076.8% | USD 22.066.8% | |
| NVAX (Novavax Inc) | 85,838 | USD 752,799-3.3% | USD 8.77-3.3% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 744,5273.1% | USD 15.343.1% | |
| HROW (Harrow Health Inc) | 18,974 | USD 716,648-5.5% | USD 37.77-5.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 707,891-1.9% | USD 13.22-1.9% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 680,741-4.0% | USD 14.94-4.0% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 669,5731.9% | USD 59.161.9% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 666,640-2.7% | USD 12.95-2.7% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 663,149 | USD 31.85 | |
| ARDX (Ardelyx Inc) | 125,414 | USD 660,932 | USD 5.27 | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 657,545-2.4% | USD 13.51-2.4% | |
| INVA (Innoviva Inc) | 34,036 | USD 646,684-0.9% | USD 19-0.9% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 645,884-5.6% | USD 17.04-5.6% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 600,031-2.6% | USD 23.79-2.6% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 595,230-7.2% | USD 8.09-7.2% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 557,584-1.8% | USD 9.50001-1.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 554,4414.2% | USD 6.714.2% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 529,042-1.5% | USD 30.15-1.5% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 515,340-1.5% | USD 10-1.5% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 504,090-0.6% | USD 13.06-0.6% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 498,866-1.0% | USD 7.19999-1.0% | |
| GMAB (Genmab AS) | 22,228 | USD 485,237-1.3% | USD 21.83-1.3% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 483,6532.4% | USD 3.022.4% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 483,3893.5% | USD 19.763.5% | |
| REPL (Replimune Group Inc) | 36,624 | USD 470,2521.6% | USD 12.841.6% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 467,079-2.2% | USD 14.52-2.2% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 465,5600.4% | USD 21.410.4% | |
| ETNB (89bio Inc) | 56,783 | USD 454,264-0.4% | USD 8-0.4% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 449,9929.2% | USD 5.939.2% | |
| ERAS (Erasca Inc) | 151,442 | USD 448,268-0.7% | USD 2.96-0.7% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 444,539-4.1% | USD 29.63-4.1% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 420,336-2.3% | USD 10.29-2.3% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 416,6541.3% | USD 14.551.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 414,572-0.9% | USD 20.86-0.9% | |
| EOLS (Evolus Inc) | 33,552 | USD 403,966-1.1% | USD 12.04-1.1% | |
| CVAC (CureVac NV) | 121,688 | USD 390,618-4.7% | USD 3.21-4.7% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 390,2231.0% | USD 8.381.0% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 387,657-1.2% | USD 12.55-1.2% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 380,1282.2% | USD 3.762.2% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 373,9190.9% | USD 23.090.9% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 362,875-1.4% | USD 25-1.4% | |
| QURE (Uniqure NV) | 23,373 | USD 357,607109.7% | USD 15.3109.7% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 349,616-1.4% | USD 13.14-1.4% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 341,285-6.0% | USD 20.505-6.0% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 336,2257.3% | USD 2.347.3% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 334,407-5.0% | USD 9.01999-5.0% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 326,874-3.9% | USD 8.93001-3.9% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 316,814-6.5% | USD 3.72-6.5% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 316,732-5.7% | USD 4.43-5.7% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 306,671-2.7% | USD 2.87-2.7% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 296,5891.6% | USD 27.211.6% | |
| SVRA (Savara Inc) | 88,197 | USD 296,342-5.6% | USD 3.36-5.6% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 296,189-6.4% | USD 2.48-6.4% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 291,395-1.6% | USD 2.52-1.6% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 290,667-6.5% | USD 6.72-6.5% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 288,9982.1% | USD 9.640012.1% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 284,5212.7% | USD 12.592.7% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 276,695-0.8% | USD 3.58-0.8% | |
| HUMA (Humacyte Inc) | 63,797 | USD 271,7751.1% | USD 4.261.1% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 271,671-1.1% | USD 12.04-1.1% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 266,367-2.5% | USD 18.36-2.5% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 262,183-0.9% | USD 23.11-0.9% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 259,602-3.4% | USD 6.25999-3.4% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 257,566-4.0% | USD 9.75998-4.0% | |
| OABI (OmniAb Inc.) | 63,047 | USD 255,971 | USD 4.06 | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 255,584-6.8% | USD 6.46999-6.8% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 255,0540.9% | USD 10.080.9% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 249,8040.2% | USD 10.280.2% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 244,895-3.5% | USD 2.19-3.5% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 244,215-4.4% | USD 8.46001-4.4% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 225,188-5.4% | USD 4.06-5.4% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 222,5011.1% | USD 9.440011.1% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 207,017 | USD 3.22 | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 200,4470.8% | USD 7.240010.8% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 189,3553.1% | USD 3.313.1% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 188,814-2.8% | USD 6.19001-2.8% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 176,6470.2% | USD 5.570.2% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 171,678-2.4% | USD 8.23001-2.4% | |
| RVNC (Revance The) | 55,931 | USD 169,191-0.2% | USD 3.025-0.2% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 160,438 | USD 3.13999 | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 155,559-7.6% | USD 4.51-7.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 152,159-4.6% | USD 4.60001-4.6% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 151,994-2.8% | USD 2.11-2.8% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 151,404-3.8% | USD 1.53-3.8% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 141,618-0.6% | USD 0.731899-0.6% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 139,1261.0% | USD 4.050011.0% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 130,724-7.2% | USD 3.63001-7.2% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 129,848-7.2% | USD 3.61-7.2% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 128,1031.7% | USD 0.9151981.7% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 126,082-2.6% | USD 2.94-2.6% | |
| ALEC (Alector Inc) | 54,386 | USD 120,193-4.3% | USD 2.21-4.3% | |
| PGEN (Precigen Inc) | 142,457 | USD 111,273-2.7% | USD 0.781099-2.7% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 111,059-0.5% | USD 5.76002-0.5% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 108,665-7.6% | USD 2.78001-7.6% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 105,290-4.0% | USD 3.33999-4.0% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 104,640-7.5% | USD 0.466001-7.5% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 94,669-5.1% | USD 2.03-5.1% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 92,169-5.3% | USD 1.61-5.3% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 88,133-5.8% | USD 2.1-5.8% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 73,966-7.9% | USD 2.86501-7.9% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 45,758-8.1% | USD 1.57999-8.1% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 40,960-2.6% | USD 1.13999-2.6% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 40,301-6.9% | USD 0.4179-6.9% | |
| ME (23Andme Holding Co) | 9,642 | USD 36,640-3.8% | USD 3.80004-3.8% | |
| OKUR (OKUR) | 2,188 | USD 30,041-8.5% | USD 13.7299-8.5% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 19,073-6.8% | USD 1.09001-6.8% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 7,594-8.4% | USD 0.273806-8.4% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 42,355,3272.6% | USD 473.982.6% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,856,7711.9% | USD 277.631.9% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 29,471,2001.3% | USD 7881.3% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,651,292-0.1% | USD 255.89-0.1% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,632,4044.6% | USD 147.534.6% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,247,845-0.8% | USD 156.46-0.8% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,533,812-1.9% | USD 611.01-1.9% | |
| MRNA (Moderna Inc) | 206,666 | USD 9,434,3032.7% | USD 45.652.7% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,765,795-0.7% | USD 367-0.7% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,205,2220.6% | USD 12.80.6% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,618,862-0.1% | USD 48.43-0.1% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,476,365-5.0% | USD 72.11-5.0% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 7,252,0410.6% | USD 18.660.6% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,994,9470.8% | USD 129.120.8% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,825,5770.1% | USD 66.810.1% | |
| INSM (Insmed Inc) | 92,172 | USD 6,707,356-3.5% | USD 72.77-3.5% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,625,6980.6% | USD 1290.6% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,354,770-0.7% | USD 120.82-0.7% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,251,8680.4% | USD 26.010.4% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,881,0170.5% | USD 352.220.5% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,534,923-1.3% | USD 92.06-1.3% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,381,362-1.8% | USD 35.17-1.8% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,927,2381.0% | USD 207.621.0% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,870,611-1.1% | USD 12.22-1.1% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,811,5400.5% | USD 84.960.5% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,222,593-2.1% | USD 47.04-2.1% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,115,084-0.4% | USD 132.42-0.4% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,001,138-1.5% | USD 120.8-1.5% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,709,826-0.7% | USD 318.44-0.7% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,333,8231.4% | USD 49.061.4% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,212,732-1.5% | USD 94.57-1.5% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,186,904-0.9% | USD 50.5-0.9% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 3,043,1521.2% | USD 38.581.2% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,006,341-0.4% | USD 93.91-0.4% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,993,1592.5% | USD 29.52.5% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 2,851,377-0.5% | USD 184.4-0.5% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,765,237-0.5% | USD 31.31-0.5% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,572,711-0.3% | USD 99.76-0.3% | |
| RARE (Ultragenyx) | 49,439 | USD 2,438,331-0.1% | USD 49.32-0.1% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,430,980-3.8% | USD 56.62-3.8% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,405,882-1.9% | USD 82.95-1.9% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,392,180-4.1% | USD 19.01-4.1% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,387,290-1.4% | USD 36.37-1.4% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,314,991-3.7% | USD 36.85-3.7% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,298,023-4.8% | USD 49.84-4.8% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,279,9074.6% | USD 35.024.6% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,248,2720.3% | USD 28.70.3% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 1,976,9000.0% | USD 48.060.0% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,945,4984.3% | USD 45.484.3% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,909,0910.3% | USD 24.960.3% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,877,250-2.5% | USD 57.41-2.5% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,824,1850.2% | USD 41.630.2% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,803,245-3.2% | USD 4.8-3.2% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,753,459-3.1% | USD 42.76-3.1% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,745,681-5.1% | USD 61.65-5.1% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,702,310-1.6% | USD 42.05-1.6% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,663,8300.7% | USD 41.870.7% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,662,2498.6% | USD 18.768.6% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,653,4492.5% | USD 28.652.5% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,645,569-2.0% | USD 51.65-2.0% | |
| MRUS (Merus BV) | 36,597 | USD 1,600,753-2.0% | USD 43.74-2.0% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,561,4271.0% | USD 9.831.0% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,556,021-0.7% | USD 40.2-0.7% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,550,131-1.4% | USD 23.27-1.4% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,544,109-2.8% | USD 28.67-2.8% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,524,519-7.2% | USD 30.24-7.2% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,512,036-6.5% | USD 43.65-6.5% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,503,5720.0% | USD 56.360.0% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,481,526-21.1% | USD 48.64-21.1% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,455,271-1.0% | USD 8.94-1.0% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,396,2993.2% | USD 8.273.2% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,393,848-2.0% | USD 47.51-2.0% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,351,730-4.1% | USD 67.14-4.1% | |
| GERN (Geron Corporation) | 324,203 | USD 1,290,3281.3% | USD 3.981.3% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,273,685-3.7% | USD 40.5-3.7% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,256,557-0.2% | USD 27.73-0.2% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,214,7053.0% | USD 27.5153.0% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,183,716-1.8% | USD 49.07-1.8% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,153,9610.0% | USD 31.120.0% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,151,301-6.8% | USD 116.34-6.8% | |
| AMPH (Amphastar P) | 26,228 | USD 1,149,5730.1% | USD 43.830.1% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,109,7554.1% | USD 34.724.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,103,582-3.0% | USD 43.31-3.0% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,092,734-1.3% | USD 36.68-1.3% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,089,4834.0% | USD 22.534.0% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 1,026,332-0.7% | USD 15.16-0.7% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,026,118-2.2% | USD 50.66-2.2% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,022,345-0.8% | USD 33.48-0.8% | |
| MNKD (MannKind Corp) | 149,905 | USD 998,367-2.1% | USD 6.66-2.1% | |
| ARVN (Arvinas Inc) | 36,691 | USD 920,210-3.2% | USD 25.08-3.2% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 911,049-0.1% | USD 12.84-0.1% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 870,6451.6% | USD 7.731.6% | |
| XNCR (Xencor Inc) | 33,378 | USD 841,126-0.6% | USD 25.2-0.6% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 797,9453.4% | USD 28.913.4% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 796,454-0.7% | USD 14.62-0.7% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 791,324-2.3% | USD 18.77-2.3% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 780,6901.5% | USD 12.581.5% | |
| NVAX (Novavax Inc) | 85,838 | USD 778,5511.5% | USD 9.071.5% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 776,471-2.8% | USD 9.35-2.8% | |
| HROW (Harrow Health Inc) | 18,974 | USD 758,0111.6% | USD 39.951.6% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 722,201-1.7% | USD 14.88-1.7% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 721,278-2.0% | USD 13.47-2.0% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 713,741-3.3% | USD 20.66-3.3% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 710,2872.2% | USD 9.132.2% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 708,991-8.5% | USD 15.56-8.5% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 685,172-5.1% | USD 13.31-5.1% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 684,546-3.3% | USD 18.06-3.3% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 673,607-0.4% | USD 13.84-0.4% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 663,1491.0% | USD 31.851.0% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 660,932-7.9% | USD 5.27-7.9% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 656,7841.9% | USD 58.031.9% | |
| INVA (Innoviva Inc) | 34,036 | USD 652,4700.6% | USD 19.170.6% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 641,5834.4% | USD 8.724.4% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 615,921-3.9% | USD 24.42-3.9% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 567,5618.8% | USD 9.669998.8% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 537,1142.1% | USD 30.612.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 532,1312.7% | USD 6.442.7% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 523,0701.5% | USD 10.151.5% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 507,178-7.8% | USD 13.14-7.8% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 503,716-0.4% | USD 7.26999-0.4% | |
| GMAB (Genmab AS) | 22,228 | USD 491,4611.4% | USD 22.111.4% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 477,6951.1% | USD 14.851.1% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 472,443-1.7% | USD 2.95-1.7% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 466,999-0.9% | USD 19.09-0.9% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 463,743-0.9% | USD 30.91-0.9% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 463,603-0.9% | USD 21.32-0.9% | |
| REPL (Replimune Group Inc) | 36,624 | USD 462,927-3.4% | USD 12.64-3.4% | |
| ETNB (89bio Inc) | 56,783 | USD 455,967-0.5% | USD 8.02999-0.5% | |
| ERAS (Erasca Inc) | 151,442 | USD 451,297-1.7% | USD 2.98-1.7% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 430,140-1.3% | USD 10.53-1.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 418,3485.5% | USD 21.055.5% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 412,0507.5% | USD 5.437.5% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 411,4992.3% | USD 14.372.3% | |
| CVAC (CureVac NV) | 121,688 | USD 410,0898.7% | USD 3.378.7% | |
| EOLS (Evolus Inc) | 33,552 | USD 408,663-3.8% | USD 12.18-3.8% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 392,290-2.8% | USD 12.7-2.8% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 386,4982.0% | USD 8.32.0% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 372,041 | USD 3.68 | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 370,519-7.8% | USD 22.88-7.8% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 368,100-2.2% | USD 25.36-2.2% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 363,1720.9% | USD 21.820.9% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 354,6710.9% | USD 13.330.9% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 351,832-4.1% | USD 9.48999-4.1% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 340,0513.2% | USD 9.293.2% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 338,95716.0% | USD 3.9816.0% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 336,0362.0% | USD 4.72.0% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 316,49215.2% | USD 2.6515.2% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 315,2190.3% | USD 2.950.3% | |
| SVRA (Savara Inc) | 88,197 | USD 313,981-4.3% | USD 3.56-4.3% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 313,2357.4% | USD 2.187.4% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 310,99611.1% | USD 7.1899911.1% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 296,0203.2% | USD 2.563.2% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 291,902-0.8% | USD 26.78-0.8% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 283,002-9.7% | USD 9.44001-9.7% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 279,013-1.6% | USD 3.61-1.6% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 277,0644.8% | USD 12.264.8% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 274,604-1.0% | USD 12.17-1.0% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 274,151-0.3% | USD 6.94-0.3% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 273,186-1.4% | USD 18.83-1.4% | |
| HUMA (Humacyte Inc) | 63,797 | USD 268,904-12.7% | USD 4.21499-12.7% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 268,7265.5% | USD 6.480015.5% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 268,3866.2% | USD 10.176.2% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 264,5650.5% | USD 23.320.5% | |
| OABI (OmniAb Inc.) | 63,047 | USD 255,9711.0% | USD 4.061.0% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 255,4731.6% | USD 8.851.6% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 253,8403.7% | USD 2.273.7% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 252,7771.1% | USD 9.991.1% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 249,318-2.7% | USD 10.26-2.7% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 237,9450.9% | USD 4.290.9% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 220,144-4.8% | USD 9.34001-4.8% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 207,017-1.5% | USD 3.22-1.5% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 198,785-2.3% | USD 7.17998-2.3% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 194,304-1.2% | USD 6.37-1.2% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 183,634-5.2% | USD 3.20999-5.2% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 176,330-0.9% | USD 5.56001-0.9% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 175,8501.3% | USD 8.430011.3% | |
| QURE (Uniqure NV) | 23,373 | USD 170,506-2.1% | USD 7.295-2.1% | |
| RVNC (Revance The) | 55,931 | USD 169,471-20.7% | USD 3.03-20.7% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 168,321-5.1% | USD 4.88-5.1% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 160,438-0.3% | USD 3.13999-0.3% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 159,436-0.4% | USD 4.82-0.4% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 157,3421.9% | USD 1.591.9% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 156,3161.4% | USD 2.171.4% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 142,4314.4% | USD 0.73614.4% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 140,807-0.8% | USD 3.91-0.8% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 139,91911.1% | USD 3.8899911.1% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 137,7520.5% | USD 4.010010.5% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 129,5132.7% | USD 3.020012.7% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 125,976-0.5% | USD 0.900002-0.5% | |
| ALEC (Alector Inc) | 54,386 | USD 125,6326.9% | USD 2.310016.9% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 117,655-3.5% | USD 3.01-3.5% | |
| PGEN (Precigen Inc) | 142,457 | USD 114,4073.4% | USD 0.8030983.4% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 113,1284.4% | USD 0.5038014.4% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 111,637-5.1% | USD 5.79-5.1% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 109,704-0.6% | USD 3.48002-0.6% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 99,7990.5% | USD 2.140.5% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 97,322 | USD 1.70001 | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 93,5894.2% | USD 2.230014.2% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 80,291-5.6% | USD 3.11001-5.6% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 49,8136.2% | USD 1.726.2% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 43,300-1.4% | USD 0.448998-1.4% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 42,0381.7% | USD 1.171.7% | |
| ME (23Andme Holding Co) | 9,642 | USD 38,086-2.5% | USD 3.95001-2.5% | |
| OKUR (OKUR) | 2,188 | USD 32,8205.9% | USD 155.9% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 20,47310.9% | USD 1.1700210.9% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 8,2873.7% | USD 0.2987923.7% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,293,7180.5% | USD 462.10.5% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,186,358-0.6% | USD 272.58-0.6% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 29,097,2001.3% | USD 7781.3% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,676,8151.8% | USD 256.261.8% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,351,176-0.9% | USD 157.78-0.9% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,080,9720.8% | USD 141.090.8% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,742,416-0.5% | USD 623.11-0.5% | |
| MRNA (Moderna Inc) | 206,666 | USD 9,184,2373.5% | USD 44.443.5% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,829,568-1.3% | USD 369.67-1.3% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,153,940-1.3% | USD 12.72-1.3% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,871,3861.3% | USD 75.921.3% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,623,582-0.1% | USD 48.46-0.1% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 7,205,4045.8% | USD 18.545.8% | |
| INSM (Insmed Inc) | 92,172 | USD 6,949,7690.1% | USD 75.40.1% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,941,8561.4% | USD 128.141.4% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,818,4250.9% | USD 66.740.9% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,583,0681.5% | USD 128.171.5% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,402,1072.4% | USD 121.722.4% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,227,831-1.8% | USD 25.91-1.8% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,852,7992.4% | USD 350.532.4% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,610,0773.6% | USD 93.313.6% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,480,818-0.6% | USD 35.82-0.6% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,926,4122.3% | USD 12.362.3% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,879,7742.0% | USD 205.622.0% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,788,3200.5% | USD 84.550.5% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,315,0521.6% | USD 48.071.6% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,133,1080.7% | USD 1330.7% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,060,426-0.4% | USD 122.59-0.4% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,737,7862.5% | USD 320.842.5% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,288,9740.7% | USD 48.40.7% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,260,2930.9% | USD 95.970.9% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,215,9331.1% | USD 50.961.1% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,019,1460.6% | USD 94.310.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 3,006,0793.7% | USD 38.113.7% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,921,1208.0% | USD 28.798.0% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 2,864,5213.1% | USD 185.253.1% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,778,4840.9% | USD 31.460.9% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,581,4791.8% | USD 100.11.8% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,527,5832.0% | USD 58.872.0% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,494,1092.6% | USD 19.822.6% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,452,288-2.2% | USD 84.55-2.2% | |
| RARE (Ultragenyx) | 49,439 | USD 2,441,2984.3% | USD 49.384.3% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,420,110-0.6% | USD 36.87-0.6% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,412,8325.7% | USD 52.335.7% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,404,1983.8% | USD 38.273.8% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,242,0050.8% | USD 28.620.8% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,180,2990.1% | USD 33.490.1% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 1,976,077-0.7% | USD 48.04-0.7% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,925,6441.9% | USD 58.891.9% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,903,7376.7% | USD 24.896.7% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,877,4934.5% | USD 61.644.5% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,864,6494.1% | USD 43.594.1% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,863,3538.5% | USD 4.968.5% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,840,257-2.0% | USD 64.99-2.0% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,820,241-0.3% | USD 41.54-0.3% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,809,6393.0% | USD 44.133.0% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,729,4343.2% | USD 42.723.2% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,679,0223.9% | USD 52.73.9% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,651,511-0.5% | USD 41.56-0.5% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,642,9923.2% | USD 32.593.2% | |
| MRUS (Merus BV) | 36,597 | USD 1,634,0561.8% | USD 44.651.8% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,616,6495.9% | USD 46.675.9% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,613,6285.1% | USD 27.965.1% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,588,8116.3% | USD 29.56.3% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,572,7805.9% | USD 23.615.9% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,567,6341.2% | USD 40.51.2% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,545,542-0.3% | USD 9.73-0.3% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,531,1123.4% | USD 17.283.4% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,503,839-0.3% | USD 56.37-0.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,469,9216.6% | USD 9.036.6% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,421,7190.7% | USD 48.460.7% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,409,3108.3% | USD 708.3% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,352,40021.5% | USD 8.0121.5% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,322,7450.9% | USD 42.060.9% | |
| GERN (Geron Corporation) | 324,203 | USD 1,274,118-1.3% | USD 3.93-1.3% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,259,2765.4% | USD 27.795.4% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,235,3181.1% | USD 124.831.1% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,205,4266.0% | USD 49.976.0% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,179,1665.5% | USD 26.715.5% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,153,5904.7% | USD 31.114.7% | |
| AMPH (Amphastar P) | 26,228 | USD 1,148,7860.5% | USD 43.80.5% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,138,2360.6% | USD 44.670.6% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,107,3310.5% | USD 37.170.5% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,065,9666.8% | USD 33.356.8% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,049,0062.9% | USD 51.792.9% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,047,896-8.1% | USD 21.67-8.1% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 1,033,7795.7% | USD 15.275.7% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,030,8950.8% | USD 33.760.8% | |
| MNKD (MannKind Corp) | 149,905 | USD 1,019,3541.0% | USD 6.81.0% | |
| ARVN (Arvinas Inc) | 36,691 | USD 951,0314.8% | USD 25.924.8% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 911,7590.2% | USD 12.850.2% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 857,130-2.9% | USD 7.61-2.9% | |
| XNCR (Xencor Inc) | 33,378 | USD 845,7990.1% | USD 25.340.1% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 810,296-1.0% | USD 19.22-1.0% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 801,9017.8% | USD 14.727.8% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 798,8934.8% | USD 9.624.8% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 775,0611.3% | USD 17.011.3% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 772,000-0.1% | USD 27.97-0.1% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 769,5190.7% | USD 12.40.7% | |
| NVAX (Novavax Inc) | 85,838 | USD 767,3927.7% | USD 8.947.7% | |
| HROW (Harrow Health Inc) | 18,974 | USD 746,0585.1% | USD 39.325.1% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 738,2696.5% | USD 21.376.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 736,2712.2% | USD 13.752.2% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 734,335-7.5% | USD 15.13-7.5% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 721,7220.1% | USD 14.020.1% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 717,3684.0% | USD 5.724.0% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 707,6686.7% | USD 18.676.7% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 694,7270.6% | USD 8.930.6% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 676,0404.3% | USD 13.894.3% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 656,2781.8% | USD 31.521.8% | |
| INVA (Innoviva Inc) | 34,036 | USD 648,3860.7% | USD 19.050.7% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 644,7861.8% | USD 56.971.8% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 641,1439.3% | USD 25.429.3% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 614,3604.8% | USD 8.350014.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 550,0220.4% | USD 14.250.4% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 525,8840.3% | USD 29.970.3% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 521,781-1.1% | USD 8.89-1.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 518,0843.3% | USD 6.273.3% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 515,3400.5% | USD 100.5% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 505,7953.1% | USD 7.33.1% | |
| GMAB (Genmab AS) | 22,228 | USD 484,793-0.2% | USD 21.81-0.2% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 480,4505.3% | USD 35.3% | |
| REPL (Replimune Group Inc) | 36,624 | USD 479,0420.2% | USD 13.080.2% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 472,5482.9% | USD 14.692.9% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 471,4023.2% | USD 19.273.2% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 467,944-3.0% | USD 31.19-3.0% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 467,7352.5% | USD 21.512.5% | |
| ERAS (Erasca Inc) | 151,442 | USD 458,8694.5% | USD 3.034.5% | |
| ETNB (89bio Inc) | 56,783 | USD 458,2392.3% | USD 8.072.3% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 435,859-0.4% | USD 10.67-0.4% | |
| EOLS (Evolus Inc) | 33,552 | USD 424,768-0.2% | USD 12.66-0.2% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 403,4105.0% | USD 13.065.0% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 402,3360.9% | USD 14.050.9% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 401,7734.9% | USD 24.814.9% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 396,4863.9% | USD 19.953.9% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 383,214-0.8% | USD 5.05-0.8% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 379,0477.1% | USD 8.139997.1% | |
| CVAC (CureVac NV) | 121,688 | USD 377,2332.0% | USD 3.12.0% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 376,3747.9% | USD 25.937.9% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 372,0411.4% | USD 3.681.4% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 367,0333.6% | USD 9.900013.6% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 359,843-3.5% | USD 21.62-3.5% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 351,4788.1% | USD 13.218.1% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 329,6017.7% | USD 4.617.7% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 329,4365.9% | USD 95.9% | |
| SVRA (Savara Inc) | 88,197 | USD 328,0933.3% | USD 3.723.3% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 314,1510.7% | USD 2.940.7% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 313,2811.7% | USD 10.451.7% | |
| HUMA (Humacyte Inc) | 63,797 | USD 308,1407.6% | USD 4.830017.6% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 294,1910.1% | USD 26.990.1% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 292,1162.7% | USD 3.432.7% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 291,6832.5% | USD 2.032.5% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 286,7704.2% | USD 2.484.2% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 283,651-1.6% | USD 3.67-1.6% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 279,8535.9% | USD 6.469995.9% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 277,3120.7% | USD 12.290.7% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 276,9586.9% | USD 19.096.9% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 274,9414.3% | USD 6.964.3% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 274,6910.2% | USD 2.30.2% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 264,4086.1% | USD 11.76.1% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 263,3171.3% | USD 23.211.3% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 256,1222.3% | USD 10.542.3% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 254,6262.0% | USD 6.142.0% | |
| OABI (OmniAb Inc.) | 63,047 | USD 253,4493.9% | USD 4.023.9% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 252,8169.6% | USD 9.579999.6% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 251,4326.7% | USD 8.710026.7% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 249,9940.4% | USD 9.880010.4% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 244,8952.3% | USD 2.192.3% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 235,7260.9% | USD 4.250.9% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 231,2228.3% | USD 9.810018.3% | |
| RVNC (Revance The) | 55,931 | USD 213,656-3.0% | USD 3.81999-3.0% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 210,23210.1% | USD 3.2700110.1% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 203,4927.8% | USD 7.357.8% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 196,7443.4% | USD 6.449993.4% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 193,646-2.4% | USD 3.38501-2.4% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 177,9160.2% | USD 5.610010.2% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 177,2893.4% | USD 5.143.4% | |
| QURE (Uniqure NV) | 23,373 | USD 174,12913.1% | USD 7.4500113.1% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 173,5554.1% | USD 8.319994.1% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 160,949-0.9% | USD 3.15-0.9% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 160,0981.3% | USD 4.840011.3% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 154,3734.7% | USD 1.564.7% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 154,15511.5% | USD 2.1411.5% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 141,8873.4% | USD 3.939993.4% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 137,0644.2% | USD 3.989994.2% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 136,4338.5% | USD 0.7051028.5% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 126,564-1.7% | USD 0.904203-1.7% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 126,0820.3% | USD 2.940.3% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 125,8924.8% | USD 3.500014.8% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 121,95524.3% | USD 3.1200124.3% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 117,614-1.5% | USD 6.09999-1.5% | |
| ALEC (Alector Inc) | 54,386 | USD 117,474-1.8% | USD 2.16-1.8% | |
| PGEN (Precigen Inc) | 142,457 | USD 110,6320.5% | USD 0.7765990.5% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 110,3343.2% | USD 3.53.2% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 108,322-1.8% | USD 0.482398-1.8% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 99,3338.1% | USD 2.130018.1% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 97,32212.6% | USD 1.7000112.6% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 89,81212.0% | USD 2.1400112.0% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 85,0671.4% | USD 3.2951.4% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 46,917-10.5% | USD 1.62001-10.5% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 43,8982.6% | USD 0.4551992.6% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 41,32011.7% | USD 1.1500111.7% | |
| ME (23Andme Holding Co) | 9,642 | USD 39,05012.2% | USD 4.0499912.2% | |
| OKUR (OKUR) | 2,188 | USD 30,982-0.3% | USD 14.16-0.3% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 18,4601.9% | USD 1.054981.9% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 7,9882.7% | USD 0.2880122.7% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,098,911-0.9% | USD 459.92-0.9% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,418,679-1.4% | USD 274.33-1.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 28,719,4601.8% | USD 767.91.8% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,369,854-1.1% | USD 251.81-1.1% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,467,032-1.0% | USD 159.26-1.0% | |
| ILMN (Illumina Inc) | 85,626 | USD 11,979,934-1.8% | USD 139.91-1.8% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,794,3090.2% | USD 626.120.2% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,941,8270.0% | USD 374.370.0% | |
| MRNA (Moderna Inc) | 206,666 | USD 8,874,2383.1% | USD 42.943.1% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,262,915-1.2% | USD 12.89-1.2% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,767,7060.4% | USD 74.920.4% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,631,4481.0% | USD 48.511.0% | |
| INSM (Insmed Inc) | 92,172 | USD 6,943,3170.0% | USD 75.330.0% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,848,677-1.0% | USD 126.42-1.0% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 6,808,990-0.5% | USD 17.52-0.5% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,759,170-0.5% | USD 66.16-0.5% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,485,993-0.2% | USD 126.28-0.2% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,343,2061.1% | USD 26.391.1% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,250,6273.6% | USD 118.843.6% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,715,383-1.2% | USD 342.3-1.2% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,514,4800.8% | USD 36.040.8% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,413,475-3.2% | USD 90.04-3.2% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,814,810-0.2% | USD 12.08-0.2% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,785,7951.3% | USD 201.661.3% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,762,269-2.2% | USD 84.09-2.2% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,245,932-2.0% | USD 47.3-2.0% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,104,2070.8% | USD 132.070.8% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,078,643-0.3% | USD 123.14-0.3% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,647,033-1.7% | USD 313.05-1.7% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,265,869-1.1% | USD 48.06-1.1% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,230,058-1.5% | USD 95.08-1.5% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,180,593-0.1% | USD 50.4-0.1% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,000,578-0.5% | USD 93.73-0.5% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 2,898,803-1.1% | USD 36.75-1.1% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 2,779,629-4.2% | USD 179.76-4.2% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,754,6380.4% | USD 31.190.4% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,705,004-1.6% | USD 26.66-1.6% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,536,348-1.2% | USD 98.35-1.2% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,506,5260.7% | USD 86.420.7% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,476,9201.0% | USD 57.691.0% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,435,863-2.6% | USD 37.11-2.6% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,430,561-3.2% | USD 19.315-3.2% | |
| RARE (Ultragenyx) | 49,439 | USD 2,340,4420.5% | USD 47.340.5% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,316,875-2.8% | USD 36.88-2.8% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,282,807-3.2% | USD 49.51-3.2% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,224,771-0.4% | USD 28.4-0.4% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,177,695-2.0% | USD 33.45-2.0% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 1,990,886-2.9% | USD 48.4-2.9% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,890,656-4.2% | USD 57.82-4.2% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,877,351-0.8% | USD 66.3-0.8% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,825,500-1.9% | USD 41.66-1.9% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,796,167-0.8% | USD 58.97-0.8% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,790,6455.3% | USD 41.865.3% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,783,654-1.6% | USD 23.32-1.6% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,756,740-2.8% | USD 42.84-2.8% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,716,839-3.6% | USD 4.57-3.6% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,676,401-2.2% | USD 41.41-2.2% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,659,062-1.3% | USD 41.75-1.3% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,616,576-3.2% | USD 50.74-3.2% | |
| MRUS (Merus BV) | 36,597 | USD 1,605,144-3.6% | USD 43.86-3.6% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,591,570-1.5% | USD 31.57-1.5% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,550,308-1.0% | USD 9.76-1.0% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,549,0540.4% | USD 40.020.4% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,535,139-9.0% | USD 26.6-9.0% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,526,931-4.2% | USD 44.08-4.2% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,507,841-2.8% | USD 56.52-2.8% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,494,021-5.8% | USD 27.74-5.8% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,485,515-3.5% | USD 22.3-3.5% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,480,606-2.7% | USD 16.71-2.7% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,411,451-2.7% | USD 48.11-2.7% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,378,764-3.0% | USD 8.47-3.0% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,310,7942.7% | USD 41.682.7% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,300,793-4.7% | USD 64.61-4.7% | |
| GERN (Geron Corporation) | 324,203 | USD 1,290,328-0.5% | USD 3.98-0.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,222,2552.1% | USD 123.512.1% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,194,930-7.0% | USD 26.37-7.0% | |
| AMPH (Amphastar P) | 26,228 | USD 1,143,541-1.6% | USD 43.6-1.6% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,139,774-0.7% | USD 23.57-0.7% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,137,641-9.3% | USD 47.16-9.3% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,131,356-2.4% | USD 44.4-2.4% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,117,802-2.7% | USD 25.32-2.7% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,112,649-7.6% | USD 6.59-7.6% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,101,969-0.4% | USD 36.99-0.4% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,101,306-3.9% | USD 29.7-3.9% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,022,651-4.1% | USD 33.49-4.1% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,019,232-2.6% | USD 50.32-2.6% | |
| MNKD (MannKind Corp) | 149,905 | USD 1,008,861-1.0% | USD 6.73-1.0% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 998,524-6.9% | USD 31.24-6.9% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 977,588-0.4% | USD 14.44-0.4% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 910,340-0.5% | USD 12.83-0.5% | |
| ARVN (Arvinas Inc) | 36,691 | USD 907,735-2.6% | USD 24.74-2.6% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 883,0357.0% | USD 7.847.0% | |
| XNCR (Xencor Inc) | 33,378 | USD 845,131-3.4% | USD 25.32-3.4% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 818,3060.2% | USD 19.410.2% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 794,033-1.4% | USD 16.36-1.4% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 772,828-1.1% | USD 28-1.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 765,492-0.7% | USD 16.8-0.7% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 763,934-2.4% | USD 12.31-2.4% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 762,353-3.2% | USD 9.18-3.2% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 743,611-5.8% | USD 13.65-5.8% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 720,743-2.5% | USD 13.46-2.5% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 720,692-2.9% | USD 14-2.9% | |
| NVAX (Novavax Inc) | 85,838 | USD 712,455 | USD 8.3 | |
| HROW (Harrow Health Inc) | 18,974 | USD 710,007-1.7% | USD 37.42-1.7% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 693,013-3.7% | USD 20.06-3.7% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 690,8371.8% | USD 8.881.8% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 689,777-1.4% | USD 5.5-1.4% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 662,9411.9% | USD 17.491.9% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 648,298-1.9% | USD 13.32-1.9% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 644,826-2.5% | USD 30.97-2.5% | |
| INVA (Innoviva Inc) | 34,036 | USD 643,9610.3% | USD 18.920.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 633,695-1.5% | USD 55.99-1.5% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 586,412-1.9% | USD 23.25-1.9% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 586,401-4.8% | USD 7.97-4.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 548,0920.6% | USD 14.20.6% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 527,650-2.4% | USD 8.99-2.4% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 524,129-4.0% | USD 29.87-4.0% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 512,763-0.1% | USD 9.94999-0.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 501,558-1.1% | USD 6.07-1.1% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 490,552-2.7% | USD 7.08-2.7% | |
| GMAB (Genmab AS) | 22,228 | USD 485,6820.9% | USD 21.850.9% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 482,4960.9% | USD 32.160.9% | |
| REPL (Replimune Group Inc) | 36,624 | USD 477,943-0.9% | USD 13.05-0.9% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 459,359-2.9% | USD 14.28-2.9% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 456,724-2.2% | USD 18.67-2.2% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 456,428-1.7% | USD 2.85-1.7% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 456,210-0.7% | USD 20.98-0.7% | |
| ETNB (89bio Inc) | 56,783 | USD 448,018-4.9% | USD 7.89-4.9% | |
| ERAS (Erasca Inc) | 151,442 | USD 439,182-7.3% | USD 2.9-7.3% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 437,493-2.1% | USD 10.71-2.1% | |
| EOLS (Evolus Inc) | 33,552 | USD 425,775-2.1% | USD 12.69-2.1% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 398,899-4.1% | USD 13.93-4.1% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 386,250-6.0% | USD 5.09001-6.0% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 384,259-4.0% | USD 12.44-4.0% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 383,150-1.7% | USD 23.66-1.7% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 381,780-2.4% | USD 19.21-2.4% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 372,99210.8% | USD 22.4110.8% | |
| CVAC (CureVac NV) | 121,688 | USD 369,9325.2% | USD 3.045.2% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 366,986-2.9% | USD 3.63-2.9% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 354,427-2.4% | USD 9.55999-2.4% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 353,902-16.1% | USD 7.60001-16.1% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 348,795-6.1% | USD 24.03-6.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 325,138-2.6% | USD 12.22-2.6% | |
| SVRA (Savara Inc) | 88,197 | USD 317,5095.0% | USD 3.65.0% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 312,014-4.3% | USD 2.92-4.3% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 311,134-5.0% | USD 8.5-5.0% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 308,1841.9% | USD 10.281.9% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 306,007-2.5% | USD 4.28-2.5% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 293,755-0.4% | USD 26.95-0.4% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 288,2884.5% | USD 3.734.5% | |
| HUMA (Humacyte Inc) | 63,797 | USD 286,4491.4% | USD 4.490011.4% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 284,498-4.8% | USD 1.98-4.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 284,451-5.9% | USD 3.34-5.9% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 275,506-2.0% | USD 12.21-2.0% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 275,207-3.1% | USD 2.38-3.1% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 274,094-12.1% | USD 2.295-12.1% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 264,282-7.8% | USD 6.11-7.8% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 263,485-0.4% | USD 6.67-0.4% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 260,027-3.0% | USD 22.92-3.0% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 258,9683.7% | USD 17.853.7% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 250,290-0.8% | USD 10.3-0.8% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 249,649-4.1% | USD 6.01999-4.1% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 249,267-3.7% | USD 11.03-3.7% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 248,9822.6% | USD 9.840022.6% | |
| OABI (OmniAb Inc.) | 63,047 | USD 243,9921.0% | USD 3.871.0% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 239,303-5.1% | USD 2.14-5.1% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 235,555-3.9% | USD 8.16001-3.9% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 233,508-0.7% | USD 4.21001-0.7% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 230,649-4.6% | USD 8.74002-4.6% | |
| RVNC (Revance The) | 55,931 | USD 220,368-5.5% | USD 3.94-5.5% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 213,426-4.3% | USD 9.05499-4.3% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 198,508-1.4% | USD 3.47-1.4% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 190,944-6.9% | USD 2.97-6.9% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 190,339-0.8% | USD 6.24001-0.8% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 188,819-4.5% | USD 6.82002-4.5% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 177,598-0.2% | USD 5.59999-0.2% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 171,425-5.5% | USD 4.96999-5.5% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 166,671-2.4% | USD 7.98998-2.4% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 162,482-0.6% | USD 3.18-0.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 158,113-1.2% | USD 4.78-1.2% | |
| QURE (Uniqure NV) | 23,373 | USD 154,0284.8% | USD 6.594.8% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 147,446-6.9% | USD 1.49-6.9% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 138,307-13.7% | USD 1.92-13.7% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 137,2061.3% | USD 3.810011.3% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 131,5689.1% | USD 3.839.1% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 128,775-2.3% | USD 0.919999-2.3% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 125,771-5.1% | USD 0.649999-5.1% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 125,653-5.9% | USD 2.93-5.9% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 120,136-1.5% | USD 3.33999-1.5% | |
| ALEC (Alector Inc) | 54,386 | USD 119,6490.5% | USD 2.20.5% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 119,349-7.6% | USD 6.18998-7.6% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 110,276-1.8% | USD 0.4911-1.8% | |
| PGEN (Precigen Inc) | 142,457 | USD 110,119-4.0% | USD 0.772998-4.0% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 106,866-2.9% | USD 3.38999-2.9% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 98,111-3.5% | USD 2.51-3.5% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 91,871-3.2% | USD 1.97-3.2% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 86,444-11.7% | USD 1.50999-11.7% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 83,905-7.4% | USD 3.24999-7.4% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 80,159-4.0% | USD 1.91-4.0% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 52,41916.0% | USD 1.8099916.0% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 42,799-39.7% | USD 0.443803-39.7% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 37,008-2.8% | USD 1.03-2.8% | |
| ME (23Andme Holding Co) | 9,642 | USD 34,8085.9% | USD 3.610045.9% | |
| OKUR (OKUR) | 2,188 | USD 31,0700.1% | USD 14.20020.1% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 18,110-1.9% | USD 1.03498-1.9% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 7,777-7.9% | USD 0.280404-7.9% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,461,7171.5% | USD 463.981.5% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,940,4060.0% | USD 278.260.0% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 28,209,3240.6% | USD 754.260.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,570,5861.1% | USD 254.721.1% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,596,9790.0% | USD 160.920.0% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,201,7051.4% | USD 142.51.4% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,774,3103.0% | USD 624.963.0% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,942,5441.5% | USD 374.41.5% | |
| MRNA (Moderna Inc) | 206,666 | USD 8,603,506-2.2% | USD 41.63-2.2% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,359,0700.3% | USD 13.040.3% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,736,6023.6% | USD 74.623.6% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,552,789-0.3% | USD 48.01-0.3% | |
| INSM (Insmed Inc) | 92,172 | USD 6,946,0824.0% | USD 75.364.0% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,920,1871.8% | USD 127.741.8% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 6,840,082-1.0% | USD 17.6-1.0% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,794,9285.3% | USD 66.515.3% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,498,8340.4% | USD 126.530.4% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,273,500-0.9% | USD 26.1-0.9% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,032,876-0.8% | USD 114.7-0.8% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,782,3382.1% | USD 346.312.1% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,593,8443.0% | USD 93.043.0% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,473,1681.4% | USD 35.771.4% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,867,6060.8% | USD 85.950.8% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,826,767-0.1% | USD 12.11-0.1% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,724,804-3.4% | USD 199.09-3.4% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,331,2100.0% | USD 48.250.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,088,9111.5% | USD 123.451.5% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,071,267-0.3% | USD 131.01-0.3% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,710,292-0.9% | USD 318.48-0.9% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,303,2440.3% | USD 48.610.3% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,278,9770.0% | USD 96.520.0% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,183,117-2.1% | USD 50.44-2.1% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,016,265-0.6% | USD 94.22-0.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 2,930,3553.7% | USD 37.153.7% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 2,901,1680.9% | USD 187.620.9% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,749,6472.0% | USD 27.12.0% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,743,1575.4% | USD 31.065.4% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,567,037-0.9% | USD 99.54-0.9% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,510,4680.2% | USD 19.950.2% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,501,5026.5% | USD 38.116.5% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,489,993-3.2% | USD 85.85-3.2% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,452,0180.9% | USD 57.110.9% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,382,838-1.4% | USD 37.93-1.4% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,357,963-0.2% | USD 51.14-0.2% | |
| RARE (Ultragenyx) | 49,439 | USD 2,329,0710.9% | USD 47.110.9% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,234,1711.1% | USD 28.521.1% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,221,965-1.4% | USD 34.13-1.4% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 2,050,941-0.9% | USD 49.86-0.9% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,974,0390.5% | USD 60.370.5% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,892,50011.7% | USD 66.83511.7% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,860,117-2.8% | USD 42.45-2.8% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,812,718-0.8% | USD 23.7-0.8% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,810,7881.0% | USD 59.451.0% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,807,9991.0% | USD 44.091.0% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,780,7043.9% | USD 4.743.9% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,714,0500.8% | USD 42.340.8% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,701,2411.0% | USD 39.771.0% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,686,922-4.2% | USD 29.23-4.2% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,681,315-0.6% | USD 42.31-0.6% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,670,4203.6% | USD 52.433.6% | |
| MRUS (Merus BV) | 36,597 | USD 1,664,615-1.6% | USD 45.485-1.6% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,616,2730.3% | USD 32.060.3% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,594,133-1.9% | USD 46.02-1.9% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,585,5804.5% | USD 29.444.5% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,566,1920.7% | USD 9.860.7% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,551,326-0.2% | USD 58.15-0.2% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,542,4743.1% | USD 39.853.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,539,473-11.4% | USD 23.11-11.4% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,521,3655.3% | USD 17.175.3% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,451,0570.2% | USD 49.460.2% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,421,087 | USD 8.73 | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,364,8168.8% | USD 67.798.8% | |
| GERN (Geron Corporation) | 324,203 | USD 1,296,8121.3% | USD 41.3% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,284,6526.3% | USD 28.356.3% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,276,200-1.6% | USD 40.58-1.6% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,254,87812.5% | USD 52.0212.5% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,203,8220.6% | USD 7.130.6% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,197,2180.9% | USD 120.980.9% | |
| AMPH (Amphastar P) | 26,228 | USD 1,161,900-1.4% | USD 44.3-1.4% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,158,621-0.3% | USD 45.47-0.3% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,148,7050.2% | USD 26.020.2% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,147,51210.0% | USD 23.7310.0% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,146,5450.6% | USD 30.920.6% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,106,7360.3% | USD 37.150.3% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,072,3590.9% | USD 33.550.9% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,066,3171.2% | USD 34.921.2% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,045,9682.5% | USD 51.642.5% | |
| MNKD (MannKind Corp) | 149,905 | USD 1,019,3541.3% | USD 6.81.3% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 981,6503.3% | USD 14.53.3% | |
| ARVN (Arvinas Inc) | 36,691 | USD 931,5845.0% | USD 25.395.0% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 914,5970.8% | USD 12.890.8% | |
| XNCR (Xencor Inc) | 33,378 | USD 874,504-1.5% | USD 26.2-1.5% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 825,5931.9% | USD 7.331.9% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 816,620-0.1% | USD 19.37-0.1% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 805,6812.3% | USD 16.62.3% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 789,372-1.1% | USD 14.49-1.1% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 787,267-0.1% | USD 9.48001-0.1% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 782,5512.8% | USD 12.612.8% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 781,384-6.1% | USD 28.31-6.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 770,9601.8% | USD 16.921.8% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 742,3136.0% | USD 14.426.0% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 738,9491.5% | USD 13.81.5% | |
| HROW (Harrow Health Inc) | 18,974 | USD 722,530-4.8% | USD 38.08-4.8% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 719,269-0.3% | USD 20.82-0.3% | |
| NVAX (Novavax Inc) | 85,838 | USD 712,455-1.3% | USD 8.3-1.3% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 699,8101.5% | USD 5.581.5% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 678,390-1.5% | USD 8.72-1.5% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 661,067-1.5% | USD 31.75-1.5% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 660,9520.6% | USD 13.580.6% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 650,4330.2% | USD 17.160.2% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 643,5410.0% | USD 56.860.0% | |
| INVA (Innoviva Inc) | 34,036 | USD 642,259-0.6% | USD 18.87-0.6% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 616,199-9.0% | USD 8.375-9.0% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 598,0140.4% | USD 23.710.4% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 546,0631.5% | USD 31.121.5% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 544,6181.1% | USD 14.111.1% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 540,5630.2% | USD 9.210010.2% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 513,2790.2% | USD 9.960010.2% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 507,342-2.5% | USD 6.14-2.5% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 504,4090.7% | USD 7.279990.7% | |
| REPL (Replimune Group Inc) | 36,624 | USD 482,3380.2% | USD 13.170.2% | |
| GMAB (Genmab AS) | 22,228 | USD 481,236-0.2% | USD 21.65-0.2% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 478,2963.6% | USD 31.883.6% | |
| ERAS (Erasca Inc) | 151,442 | USD 474,0132.0% | USD 3.132.0% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 472,8700.5% | USD 14.70.5% | |
| ETNB (89bio Inc) | 56,783 | USD 471,299-4.9% | USD 8.3-4.9% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 466,99914.4% | USD 19.0914.4% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 464,435-0.3% | USD 2.9-0.3% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 459,472-0.2% | USD 21.13-0.2% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 446,888-2.1% | USD 10.94-2.1% | |
| EOLS (Evolus Inc) | 33,552 | USD 434,834-1.1% | USD 12.96-1.1% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 421,8880.9% | USD 9.060.9% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 416,0815.4% | USD 14.535.4% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 410,9120.3% | USD 5.4150.3% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 400,3211.2% | USD 12.961.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 391,1201.2% | USD 19.681.2% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 389,9529.5% | USD 24.089.5% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 378,1079.7% | USD 3.749.7% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 371,3664.7% | USD 25.5854.7% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 363,3252.1% | USD 9.799992.1% | |
| CVAC (CureVac NV) | 121,688 | USD 351,6781.4% | USD 2.891.4% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 336,7084.5% | USD 20.234.5% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 333,918-2.5% | USD 12.55-2.5% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 327,6061.2% | USD 8.950011.2% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 325,905-4.7% | USD 3.05-4.7% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 313,872 | USD 4.39 | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 311,7151.6% | USD 2.611.6% | |
| SVRA (Savara Inc) | 88,197 | USD 302,516-2.3% | USD 3.43-2.3% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 302,4880.9% | USD 10.090.9% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 302,3360.3% | USD 3.550.3% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 298,86713.7% | USD 2.0813.7% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 295,063-1.5% | USD 27.07-1.5% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 286,774-5.4% | USD 6.63-5.4% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 283,879-5.9% | USD 2.455-5.9% | |
| HUMA (Humacyte Inc) | 63,797 | USD 282,6214.2% | USD 4.434.2% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 281,1471.0% | USD 12.461.0% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 275,9224.4% | USD 3.574.4% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 268,0821.6% | USD 23.631.6% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 264,6700.9% | USD 6.70.9% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 260,4320.5% | USD 6.280010.5% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 258,7592.9% | USD 11.452.9% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 252,234-1.8% | USD 10.38-1.8% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 252,163-2.6% | USD 2.255-2.6% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 249,828-3.8% | USD 17.22-3.8% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 245,0811.5% | USD 8.490011.5% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 242,656-2.5% | USD 9.59001-2.5% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 241,732-1.5% | USD 9.15998-1.5% | |
| OABI (OmniAb Inc.) | 63,047 | USD 241,470-2.0% | USD 3.83-2.0% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 235,172-1.4% | USD 4.24001-1.4% | |
| RVNC (Revance The) | 55,931 | USD 233,2326.4% | USD 4.176.4% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 222,972-2.8% | USD 9.45999-2.8% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 205,0881.9% | USD 3.191.9% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 201,369-4.6% | USD 3.52001-4.6% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 197,6780.8% | USD 7.140.8% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 191,864-4.3% | USD 6.29-4.3% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 181,428-1.7% | USD 5.26-1.7% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 177,9160.2% | USD 5.610010.2% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 170,843-1.8% | USD 8.18998-1.8% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 163,504-0.3% | USD 3.2-0.3% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 160,2782.1% | USD 2.2252.1% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 160,098-1.4% | USD 4.84001-1.4% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 158,331-1.8% | USD 1.6-1.8% | |
| QURE (Uniqure NV) | 23,373 | USD 147,016-1.9% | USD 6.28999-1.9% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 135,405-2.2% | USD 3.76-2.2% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 133,587-10.5% | USD 3.11501-10.5% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 132,582-3.9% | USD 0.6852-3.9% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 131,8690.4% | USD 0.9421030.4% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 129,183-2.5% | USD 6.70002-2.5% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 121,9350.9% | USD 3.390.9% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 120,576-6.9% | USD 3.51001-6.9% | |
| ALEC (Alector Inc) | 54,386 | USD 119,105-13.1% | USD 2.18999-13.1% | |
| PGEN (Precigen Inc) | 142,457 | USD 114,664-6.8% | USD 0.804903-6.8% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 112,297-1.4% | USD 0.5001-1.4% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 110,0191.5% | USD 3.490011.5% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 101,6296.1% | USD 2.600016.1% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 97,894 | USD 1.71 | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 94,902-6.2% | USD 2.035-6.2% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 90,618-1.4% | USD 3.51001-1.4% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 83,5160.5% | USD 1.989990.5% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 71,007105.4% | USD 0.736305105.4% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 45,1790.6% | USD 1.559990.6% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 38,086-3.6% | USD 1.06001-3.6% | |
| ME (23Andme Holding Co) | 9,642 | USD 32,879-1.9% | USD 3.40998-1.9% | |
| OKUR (OKUR) | 2,188 | USD 31,026-3.1% | USD 14.1801-3.1% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 18,460-12.1% | USD 1.05498-12.1% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 8,448-1.1% | USD 0.304597-1.1% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 40,835,296-1.9% | USD 456.97-1.9% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,948,3720.1% | USD 278.320.1% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 28,033,918-1.7% | USD 749.57-1.7% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,371,923-0.5% | USD 251.84-0.5% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,591,499-2.1% | USD 160.85-2.1% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,039,016-3.1% | USD 140.6-3.1% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,455,543-1.8% | USD 606.47-1.8% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,808,549-0.4% | USD 368.79-0.4% | |
| MRNA (Moderna Inc) | 206,666 | USD 8,799,838-3.8% | USD 42.58-3.8% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,333,429-1.5% | USD 13-1.5% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,577,9600.4% | USD 48.170.4% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,468,070-1.7% | USD 72.03-1.7% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 6,906,151-3.9% | USD 17.77-3.9% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,795,587-0.4% | USD 125.44-0.4% | |
| INSM (Insmed Inc) | 92,172 | USD 6,676,0180.0% | USD 72.430.0% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,472,126-1.5% | USD 126.01-1.5% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,455,743-2.8% | USD 63.19-2.8% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,331,188-0.3% | USD 26.34-0.3% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,079,687-1.4% | USD 115.59-1.4% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,664,791-0.9% | USD 339.27-0.9% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,433,316-1.3% | USD 90.37-1.3% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,395,133-0.9% | USD 35.26-0.9% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,889,0290.1% | USD 206.010.1% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,831,361-0.8% | USD 85.31-0.8% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,830,753-2.9% | USD 12.12-2.9% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,329,414-6.9% | USD 48.23-6.9% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,081,833-1.6% | USD 131.35-1.6% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,028,9600.0% | USD 121.640.0% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,743,8440.9% | USD 321.360.9% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,294,410-0.2% | USD 48.48-0.2% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,279,317-1.1% | USD 96.53-1.1% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,250,6421.7% | USD 51.511.7% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,033,2320.5% | USD 94.750.5% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 2,875,654-4.6% | USD 185.97-4.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 2,824,657-0.8% | USD 35.81-0.8% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,696,887-0.1% | USD 26.58-0.1% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,603,6150.4% | USD 29.480.4% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,591,5371.4% | USD 100.491.4% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,571,205-7.4% | USD 88.65-7.4% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,506,6931.2% | USD 19.921.2% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,429,692-1.4% | USD 56.59-1.4% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,417,391-6.8% | USD 38.48-6.8% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,362,574-7.1% | USD 51.24-7.1% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,348,5630.7% | USD 35.780.7% | |
| RARE (Ultragenyx) | 49,439 | USD 2,307,318-2.0% | USD 46.67-2.0% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,254,517-2.2% | USD 34.63-2.2% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,210,670-2.0% | USD 28.22-2.0% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 2,068,629-3.4% | USD 50.29-3.4% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,964,556-1.2% | USD 60.08-1.2% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,914,0140.9% | USD 43.680.9% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,827,251-6.8% | USD 23.89-6.8% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,793,4260.0% | USD 58.880.0% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,790,366-1.0% | USD 43.66-1.0% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,760,7932.2% | USD 30.512.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,736,653-1.0% | USD 26.07-1.0% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,713,083-8.2% | USD 4.56-8.2% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,700,286-0.3% | USD 42-0.3% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,694,99649.0% | USD 59.8649.0% | |
| MRUS (Merus BV) | 36,597 | USD 1,691,147-4.8% | USD 46.21-4.8% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,690,8521.6% | USD 42.551.6% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,684,5583.7% | USD 39.383.7% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,624,962-1.7% | USD 46.91-1.7% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,612,4350.6% | USD 50.610.6% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,611,2311.3% | USD 31.961.3% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,555,073-1.7% | USD 9.79-1.7% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,553,727-0.9% | USD 58.24-0.9% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,517,180-3.8% | USD 28.17-3.8% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,496,413-1.2% | USD 38.66-1.2% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,448,710-0.3% | USD 49.38-0.3% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,444,278-1.9% | USD 16.3-1.9% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,421,087-3.7% | USD 8.73-3.7% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,297,271-4.6% | USD 41.25-4.6% | |
| GERN (Geron Corporation) | 324,203 | USD 1,280,602-2.2% | USD 3.95-2.2% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,253,8839.8% | USD 62.289.8% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,208,071-2.9% | USD 26.66-2.9% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,197,069-6.5% | USD 7.09-6.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,186,827-2.3% | USD 119.93-2.3% | |
| AMPH (Amphastar P) | 26,228 | USD 1,178,162-2.1% | USD 44.92-2.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,161,551-1.4% | USD 45.585-1.4% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,146,939-8.2% | USD 25.98-8.2% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,140,241-3.9% | USD 30.75-3.9% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,115,9300.3% | USD 46.260.3% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,103,161-0.8% | USD 37.03-0.8% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,062,770-2.0% | USD 33.25-2.0% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,053,492-1.8% | USD 34.5-1.8% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,043,544-0.8% | USD 21.58-0.8% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,020,8520.0% | USD 50.40.0% | |
| MNKD (MannKind Corp) | 149,905 | USD 1,005,8631.8% | USD 6.711.8% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 950,508-8.1% | USD 14.04-8.1% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 907,502-1.9% | USD 12.79-1.9% | |
| XNCR (Xencor Inc) | 33,378 | USD 887,855-0.9% | USD 26.6-0.9% | |
| ARVN (Arvinas Inc) | 36,691 | USD 887,555-5.9% | USD 24.19-5.9% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 832,4463.3% | USD 30.163.3% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 817,041-1.0% | USD 19.38-1.0% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 809,824-2.6% | USD 7.19-2.6% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 798,088-6.9% | USD 14.65-6.9% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 788,097-2.9% | USD 9.49-2.9% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 787,723-2.8% | USD 16.23-2.8% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 761,452-1.2% | USD 12.27-1.2% | |
| HROW (Harrow Health Inc) | 18,974 | USD 759,339-4.4% | USD 40.02-4.4% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 757,290-0.5% | USD 16.62-0.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 727,704-1.8% | USD 13.59-1.8% | |
| NVAX (Novavax Inc) | 85,838 | USD 721,898-4.1% | USD 8.41-4.1% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 721,687-2.8% | USD 20.89-2.8% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 700,6162.2% | USD 13.612.2% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 689,777-0.7% | USD 5.5-0.7% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 688,503-2.7% | USD 8.84999-2.7% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 676,89912.9% | USD 9.212.9% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 670,853-0.8% | USD 32.22-0.8% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 657,059-6.3% | USD 13.5-6.3% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 648,9161.0% | USD 17.121.0% | |
| INVA (Innoviva Inc) | 34,036 | USD 646,344-0.7% | USD 18.99-0.7% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 643,655-1.7% | USD 56.87-1.7% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 595,491-3.4% | USD 23.61-3.4% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 539,389-3.0% | USD 9.19001-3.0% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 538,442-3.8% | USD 13.95-3.8% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 537,991-2.1% | USD 30.66-2.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 520,563-3.5% | USD 6.3-3.5% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 512,248-14.2% | USD 9.94-14.2% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 500,9451.4% | USD 7.231.4% | |
| ETNB (89bio Inc) | 56,783 | USD 495,716-7.5% | USD 8.73001-7.5% | |
| GMAB (Genmab AS) | 22,228 | USD 482,348-0.6% | USD 21.7-0.6% | |
| REPL (Replimune Group Inc) | 36,624 | USD 481,239-3.0% | USD 13.14-3.0% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 470,618-5.7% | USD 14.63-5.7% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 466,037-4.0% | USD 2.91-4.0% | |
| ERAS (Erasca Inc) | 151,442 | USD 464,927-5.0% | USD 3.07-5.0% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 461,792-2.0% | USD 30.78-2.0% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 460,342-3.1% | USD 21.17-3.1% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 456,283-0.3% | USD 11.17-0.3% | |
| EOLS (Evolus Inc) | 33,552 | USD 439,531-3.0% | USD 13.1-3.0% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 418,163-3.6% | USD 8.98001-3.6% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 409,774-5.9% | USD 5.40001-5.9% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 408,043-6.3% | USD 16.68-6.3% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 395,379-2.8% | USD 12.8-2.8% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 394,604-8.1% | USD 13.78-8.1% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 386,549-2.8% | USD 19.45-2.8% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 356,268-9.8% | USD 22-9.8% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 355,910-5.6% | USD 9.59999-5.6% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 354,747-4.8% | USD 24.44-4.8% | |
| CVAC (CureVac NV) | 121,688 | USD 346,811-2.4% | USD 2.85-2.4% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 344,744-1.4% | USD 3.41-1.4% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 342,432-4.6% | USD 12.87-4.6% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 341,933-1.8% | USD 3.2-1.8% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 323,5791.5% | USD 8.839991.5% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 322,2283.4% | USD 19.363.4% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 313,872-6.0% | USD 4.39-6.0% | |
| SVRA (Savara Inc) | 88,197 | USD 309,5716.2% | USD 3.509996.2% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 306,938-9.8% | USD 2.57-9.8% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 303,211-2.1% | USD 7.01001-2.1% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 301,802-15.3% | USD 2.61-15.3% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 301,484-2.2% | USD 3.54-2.2% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 299,790-2.1% | USD 10-2.1% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 299,641-1.8% | USD 27.49-1.8% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 278,440-4.2% | USD 12.34-4.2% | |
| HUMA (Humacyte Inc) | 63,797 | USD 271,137-4.5% | USD 4.25-4.5% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 264,3281.2% | USD 3.421.2% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 263,885-1.2% | USD 23.26-1.2% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 262,945-5.2% | USD 1.83-5.2% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 262,300-7.1% | USD 6.64-7.1% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 259,693-4.0% | USD 17.9-4.0% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 259,188-5.9% | USD 6.25001-5.9% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 258,873-9.2% | USD 2.315-9.2% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 256,851-10.3% | USD 10.57-10.3% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 251,527-10.4% | USD 11.13-10.4% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 248,9824.2% | USD 9.840024.2% | |
| OABI (OmniAb Inc.) | 63,047 | USD 246,514-1.8% | USD 3.91-1.8% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 245,427-7.0% | USD 9.3-7.0% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 241,472-4.5% | USD 8.36498-4.5% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 238,500-3.8% | USD 4.30001-3.8% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 229,336-5.3% | USD 9.73-5.3% | |
| RVNC (Revance The) | 55,931 | USD 219,2505.1% | USD 3.920015.1% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 211,094-5.1% | USD 3.69-5.1% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 201,231-9.3% | USD 3.13-9.3% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 200,405-5.2% | USD 6.57001-5.2% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 196,017-6.7% | USD 7.08-6.7% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 184,532-3.6% | USD 5.34999-3.6% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 177,598-3.3% | USD 5.59999-3.3% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 173,972-2.5% | USD 8.33998-2.5% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 164,015 | USD 3.21 | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 162,413-2.6% | USD 4.91-2.6% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 161,300-3.6% | USD 1.63-3.6% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 157,036-4.0% | USD 2.18-4.0% | |
| QURE (Uniqure NV) | 23,373 | USD 149,821-10.1% | USD 6.41-10.1% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 149,240-0.6% | USD 3.48-0.6% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 138,466-2.9% | USD 3.845-2.9% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 137,942-11.0% | USD 0.712901-11.0% | |
| ALEC (Alector Inc) | 54,386 | USD 137,0530.4% | USD 2.520010.4% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 132,460-5.5% | USD 6.86998-5.5% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 131,379-6.1% | USD 0.938602-6.1% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 129,507-2.8% | USD 3.77-2.8% | |
| PGEN (Precigen Inc) | 142,457 | USD 123,054-5.0% | USD 0.863797-5.0% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 120,856-8.2% | USD 3.36-8.2% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 113,869-3.5% | USD 0.507101-3.5% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 108,443-6.8% | USD 3.44001-6.8% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 101,198-8.4% | USD 2.17-8.4% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 97,89424.8% | USD 1.7124.8% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 95,766-2.8% | USD 2.45001-2.8% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 91,909-13.8% | USD 3.56002-13.8% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 83,097-9.6% | USD 1.98001-9.6% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 44,890-6.6% | USD 1.55002-6.6% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 39,523-3.5% | USD 1.1-3.5% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 34,573-14.0% | USD 0.358503-14.0% | |
| ME (23Andme Holding Co) | 9,642 | USD 33,506-3.6% | USD 3.47501-3.6% | |
| OKUR (OKUR) | 2,188 | USD 32,010-2.1% | USD 14.6298-2.1% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 20,9983.9% | USD 1.200023.9% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 8,545-6.4% | USD 0.308094-6.4% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,618,099-0.5% | USD 465.73-0.5% | |
| AMGN (Amgen Inc) | 132,755 | USD 36,919,166-1.7% | USD 278.1-1.7% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 28,511,5161.6% | USD 762.341.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,452,6300.0% | USD 253.010.0% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,856,0892.2% | USD 164.232.2% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,428,6140.7% | USD 145.150.7% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,645,5280.2% | USD 617.490.2% | |
| MRNA (Moderna Inc) | 206,666 | USD 9,147,0372.8% | USD 44.262.8% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,840,316-0.1% | USD 370.12-0.1% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,461,6360.8% | USD 13.20.8% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,593,523-1.8% | USD 73.24-1.8% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,544,923-1.1% | USD 47.96-1.1% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 7,185,9720.2% | USD 18.490.2% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,819,965-0.7% | USD 125.89-0.7% | |
| INSM (Insmed Inc) | 92,172 | USD 6,675,096-3.6% | USD 72.42-3.6% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,644,747-1.5% | USD 65.04-1.5% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,571,768-4.0% | USD 127.95-4.0% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,352,821-0.9% | USD 26.43-0.9% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,164,368-1.0% | USD 117.2-1.0% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,716,3850.5% | USD 342.360.5% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,507,267-2.9% | USD 91.6-2.9% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,445,626-2.4% | USD 35.59-2.4% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 4,974,241-1.8% | USD 12.48-1.8% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,882,859-4.3% | USD 205.75-4.3% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,872,1370.4% | USD 86.030.4% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 4,649,879-10.5% | USD 51.8-10.5% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,148,957-1.9% | USD 133.51-1.9% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,026,9730.0% | USD 121.580.0% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,711,108-2.9% | USD 318.55-2.9% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,316,3471.3% | USD 97.621.3% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,301,8850.8% | USD 48.590.8% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,195,107-2.4% | USD 50.63-2.4% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,017,866-2.5% | USD 94.27-2.5% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 3,013,893-1.3% | USD 194.91-1.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 2,847,5321.0% | USD 36.11.0% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,776,2638.7% | USD 95.728.7% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,698,916-1.8% | USD 26.6-1.8% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,594,549-4.0% | USD 41.3-4.0% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,593,9001.2% | USD 29.371.2% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,555,1740.9% | USD 99.080.9% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,542,8567.8% | USD 55.157.8% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,477,750-2.1% | USD 19.69-2.1% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,464,0400.3% | USD 57.390.3% | |
| RARE (Ultragenyx) | 49,439 | USD 2,353,296-0.1% | USD 47.6-0.1% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,331,497-0.3% | USD 35.52-0.3% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,305,9484.4% | USD 35.424.4% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,255,3222.1% | USD 28.792.1% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 2,141,84718.7% | USD 52.0718.7% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 1,989,407-1.9% | USD 60.84-1.9% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,960,3362.5% | USD 25.632.5% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,897,8012.9% | USD 43.312.9% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,867,110-1.4% | USD 4.97-1.4% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,809,2292.7% | USD 44.122.7% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,793,121-0.9% | USD 58.87-0.9% | |
| MRUS (Merus BV) | 36,597 | USD 1,776,0528.2% | USD 48.538.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,754,6391.2% | USD 26.341.2% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,722,70349.0% | USD 29.8549.0% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,705,144-1.2% | USD 42.12-1.2% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,663,8300.9% | USD 41.870.9% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,653,7141.9% | USD 47.741.9% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,623,815-4.9% | USD 37.96-4.9% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,602,5582.3% | USD 50.32.3% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,590,058-4.4% | USD 31.54-4.4% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,582,076-0.2% | USD 9.96-0.2% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,576,962-4.3% | USD 29.28-4.3% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,567,0661.0% | USD 58.741.0% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,513,831-1.3% | USD 39.11-1.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,476,433-2.7% | USD 9.07-2.7% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,471,7461.8% | USD 16.611.8% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,453,698-0.4% | USD 49.55-0.4% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,360,484-1.2% | USD 43.26-1.2% | |
| GERN (Geron Corporation) | 324,203 | USD 1,309,780-1.9% | USD 4.04-1.9% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,279,8007.2% | USD 7.587.2% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,249,1393.4% | USD 28.2953.4% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,243,8690.3% | USD 27.450.3% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,214,2391.0% | USD 122.71.0% | |
| AMPH (Amphastar P) | 26,228 | USD 1,203,3411.5% | USD 45.881.5% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,186,963-0.3% | USD 32.01-0.3% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,177,4770.0% | USD 46.210.0% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,142,145-1.7% | USD 56.73-1.7% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,137,737-11.1% | USD 40.18-11.1% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,113,0352.2% | USD 46.142.2% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,111,5022.0% | USD 37.312.0% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,084,8242.4% | USD 33.942.4% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,072,7301.3% | USD 35.131.3% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,051,7653.3% | USD 21.753.3% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 1,033,7791.1% | USD 15.271.1% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,021,257-3.9% | USD 50.42-3.9% | |
| MNKD (MannKind Corp) | 149,905 | USD 987,874-2.8% | USD 6.59-2.8% | |
| ARVN (Arvinas Inc) | 36,691 | USD 943,693-3.7% | USD 25.72-3.7% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 925,2401.4% | USD 13.041.4% | |
| XNCR (Xencor Inc) | 33,378 | USD 895,8664.8% | USD 26.844.8% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 856,9230.7% | USD 15.730.7% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 831,224-1.6% | USD 7.38-1.6% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 825,0524.0% | USD 19.574.0% | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 811,350-1.2% | USD 9.77-1.2% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 810,0492.6% | USD 16.692.6% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 805,9491.2% | USD 29.21.2% | |
| HROW (Harrow Health Inc) | 18,974 | USD 794,252-0.1% | USD 41.86-0.1% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 770,450-4.8% | USD 12.415-4.8% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 760,936-0.1% | USD 16.7-0.1% | |
| NVAX (Novavax Inc) | 85,838 | USD 752,7990.6% | USD 8.770.6% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 742,415-2.8% | USD 21.49-2.8% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 741,090-0.6% | USD 13.84-0.6% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 707,9532.7% | USD 9.12.7% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 701,3490.1% | USD 14.410.1% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 694,794-2.3% | USD 5.54-2.3% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 685,687-8.2% | USD 13.32-8.2% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 676,474-0.8% | USD 32.49-0.8% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 654,9731.1% | USD 57.871.1% | |
| INVA (Innoviva Inc) | 34,036 | USD 650,7680.7% | USD 19.120.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 642,473-5.4% | USD 16.95-5.4% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 616,1730.2% | USD 24.430.2% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 599,6442.4% | USD 8.149992.4% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 597,2794.8% | USD 11.594.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 559,6712.9% | USD 14.52.9% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 555,823-0.4% | USD 9.47001-0.4% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 549,7482.7% | USD 31.332.7% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 539,5679.9% | USD 6.539.9% | |
| ETNB (89bio Inc) | 56,783 | USD 536,0325.0% | USD 9.440015.0% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 498,92612.4% | USD 15.5112.4% | |
| REPL (Replimune Group Inc) | 36,624 | USD 496,255-3.8% | USD 13.55-3.8% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 494,0162.0% | USD 7.132.0% | |
| ERAS (Erasca Inc) | 151,442 | USD 489,15812.9% | USD 3.2312.9% | |
| GMAB (Genmab AS) | 22,228 | USD 485,4601.6% | USD 21.841.6% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 485,2550.7% | USD 3.030.7% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 475,128-1.0% | USD 21.85-1.0% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 471,0943.7% | USD 31.43.7% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 457,5091.4% | USD 11.21.4% | |
| EOLS (Evolus Inc) | 33,552 | USD 453,288-1.3% | USD 13.51-1.3% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 435,6865.3% | USD 17.815.3% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 435,5741.2% | USD 5.741.2% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 433,995-1.5% | USD 9.32-1.5% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 429,540-7.5% | USD 15-7.5% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 406,808-2.1% | USD 13.17-2.1% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 397,679-1.9% | USD 20.01-1.9% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 394,810-2.3% | USD 24.38-2.3% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 377,0432.7% | USD 10.172.7% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 372,455-1.5% | USD 25.66-1.5% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 358,9285.6% | USD 13.495.6% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 356,150-4.9% | USD 3.08-4.9% | |
| CVAC (CureVac NV) | 121,688 | USD 355,3291.7% | USD 2.921.7% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 349,799 | USD 3.46 | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 348,344-1.8% | USD 3.26-1.8% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 340,3782.5% | USD 2.852.5% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 333,891-0.6% | USD 4.67-0.6% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 318,821-1.8% | USD 8.71-1.8% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 311,7427.0% | USD 18.737.0% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 309,69927.6% | USD 7.1600127.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 308,2972.8% | USD 3.622.8% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 306,0860.9% | USD 10.210.9% | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 305,0911.3% | USD 27.991.3% | |
| SVRA (Savara Inc) | 88,197 | USD 291,491-1.6% | USD 3.305-1.6% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 290,6241.4% | USD 12.881.4% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 286,497-1.1% | USD 11.79-1.1% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 285,1512.8% | USD 2.552.8% | |
| HUMA (Humacyte Inc) | 63,797 | USD 283,897-1.5% | USD 4.45001-1.5% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 282,446-1.8% | USD 7.14999-1.8% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 280,680-2.7% | USD 12.42-2.7% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 277,3141.0% | USD 1.931.0% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 275,361-1.9% | USD 6.64-1.9% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 270,4291.6% | USD 18.641.6% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 267,0610.7% | USD 23.540.7% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 263,9000.8% | USD 100.8% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 261,2373.0% | USD 3.383.0% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 252,875-1.0% | USD 8.76-1.0% | |
| OABI (OmniAb Inc.) | 63,047 | USD 250,9271.8% | USD 3.981.8% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 247,929-1.8% | USD 4.47001-1.8% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 242,0642.1% | USD 10.272.1% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 238,8602.1% | USD 9.439992.1% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 222,535-1.3% | USD 3.89-1.3% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 221,8044.9% | USD 3.454.9% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 211,3861.0% | USD 6.930011.0% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 210,137-3.2% | USD 7.59001-3.2% | |
| RVNC (Revance The) | 55,931 | USD 208,6233.3% | USD 3.730013.3% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 191,4310.2% | USD 5.550010.2% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 183,6245.8% | USD 5.795.8% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 178,353 | USD 8.55 | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 167,237-5.1% | USD 1.69-5.1% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 166,713-2.1% | USD 5.04-2.1% | |
| QURE (Uniqure NV) | 23,373 | USD 166,64919.4% | USD 7.1299819.4% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 164,015-5.6% | USD 3.21-5.6% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 163,5191.3% | USD 2.269991.3% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 154,969-0.3% | USD 0.800898-0.3% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 150,0982.3% | USD 3.500012.3% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 142,608-2.7% | USD 3.96001-2.7% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 140,1730.4% | USD 7.270010.4% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 139,9735.8% | USD 15.8% | |
| ALEC (Alector Inc) | 54,386 | USD 136,509-3.1% | USD 2.51-3.1% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 133,2860.8% | USD 3.880010.8% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 131,6471.4% | USD 3.660011.4% | |
| PGEN (Precigen Inc) | 142,457 | USD 129,479-2.5% | USD 0.908899-2.5% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 118,0453.7% | USD 0.5256983.7% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 116,3242.8% | USD 3.690012.8% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 110,5258.2% | USD 2.378.2% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 106,6248.1% | USD 4.129998.1% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 98,502-6.0% | USD 2.52001-6.0% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 91,910-2.2% | USD 2.19-2.2% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 78,43012.3% | USD 1.3712.3% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 48,07512.2% | USD 1.6599912.2% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 40,960 | USD 1.13999 | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 40,2243.0% | USD 0.4171013.0% | |
| ME (23Andme Holding Co) | 9,642 | USD 34,7591.5% | USD 3.604961.5% | |
| OKUR (OKUR) | 2,188 | USD 32,711-3.0% | USD 14.9502-3.0% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 20,210-8.3% | USD 1.15499-8.3% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 9,1251.4% | USD 0.3290071.4% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,832,5650.8% | USD 468.130.8% | |
| AMGN (Amgen Inc) | 132,755 | USD 37,552,4071.0% | USD 282.871.0% | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 28,058,228-0.6% | USD 750.22-0.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,456,769-0.3% | USD 253.07-0.3% | |
| BIIB (Biogen Inc) | 78,281 | USD 12,574,2770.5% | USD 160.630.5% | |
| ILMN (Illumina Inc) | 85,626 | USD 12,342,988-0.1% | USD 144.15-0.1% | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,629,3220.3% | USD 616.550.3% | |
| MRNA (Moderna Inc) | 206,666 | USD 8,899,038-0.8% | USD 43.06-0.8% | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 8,849,154-2.0% | USD 370.49-2.0% | |
| VTRS (Viatris Inc) | 641,033 | USD 8,391,122-1.0% | USD 13.09-1.0% | |
| INCY (Incyte Corporation) | 103,680 | USD 7,733,491-1.1% | USD 74.59-1.1% | |
| SNY (Sanofi ADR) | 157,317 | USD 7,628,301-0.5% | USD 48.49-0.5% | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 7,174,313-2.5% | USD 18.46-2.5% | |
| INSM (Insmed Inc) | 92,172 | USD 6,927,648-0.9% | USD 75.16-0.9% | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,866,5550.1% | USD 126.750.1% | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 6,848,609-3.3% | USD 133.34-3.3% | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,745,8890.9% | USD 66.030.9% | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,408,1040.2% | USD 26.660.2% | |
| BNTX (BioNTech SE) | 52,597 | USD 6,226,959-1.9% | USD 118.39-1.9% | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,687,4990.5% | USD 340.630.5% | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,672,0040.4% | USD 94.340.4% | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,578,7451.5% | USD 36.461.5% | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 5,192,963-1.2% | USD 57.85-1.2% | |
| BGNE (BeiGene Ltd) | 23,732 | USD 5,102,3804.3% | USD 2154.3% | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 5,065,9140.2% | USD 12.710.2% | |
| ITCI (Intracellular Th) | 56,633 | USD 4,850,616-1.1% | USD 85.65-1.1% | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,228,822-0.2% | USD 136.08-0.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,027,304-0.9% | USD 121.59-0.9% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,823,414-1.0% | USD 328.19-1.0% | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,275,383-0.6% | USD 48.2-0.6% | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,274,2211.3% | USD 96.381.3% | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,272,729-0.7% | USD 51.86-0.7% | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,095,017-0.1% | USD 96.68-0.1% | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 3,052,7050.3% | USD 197.420.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 2,818,347-0.5% | USD 35.73-0.5% | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,748,633-1.5% | USD 27.09-1.5% | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,703,231-0.7% | USD 43.03-0.7% | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,562,988-1.0% | USD 29.02-1.0% | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,554,382-1.1% | USD 88.07-1.1% | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,532,996-1.4% | USD 98.22-1.4% | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,530,602-7.9% | USD 20.11-7.9% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,455,882-0.8% | USD 57.2-0.8% | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,359,3460.6% | USD 51.170.6% | |
| RARE (Ultragenyx) | 49,439 | USD 2,354,780-1.0% | USD 47.63-1.0% | |
| GH (Guardant Health Inc) | 65,639 | USD 2,337,4051.5% | USD 35.611.5% | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,209,103-1.8% | USD 28.2-1.8% | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,208,945-0.6% | USD 33.93-0.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 2,028,646-0.3% | USD 62.04-0.3% | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,912,150-0.6% | USD 25-0.6% | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,893,407-1.2% | USD 5.04-1.2% | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,843,465-2.5% | USD 42.07-2.5% | |
| AGIO (Agios Pharm) | 30,459 | USD 1,808,9601.2% | USD 59.391.2% | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 1,804,960-2.7% | USD 43.88-2.7% | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,761,2510.1% | USD 42.950.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,733,988-0.5% | USD 26.03-0.5% | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,725,790-1.2% | USD 42.63-1.2% | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,706,8024.6% | USD 39.94.6% | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,663,6622.5% | USD 332.5% | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,648,593-1.7% | USD 30.61-1.7% | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,648,332-0.6% | USD 41.48-0.6% | |
| MRUS (Merus BV) | 36,597 | USD 1,641,009-0.3% | USD 44.84-0.3% | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,622,8840.0% | USD 46.850.0% | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,585,2530.2% | USD 9.980.2% | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,566,8751.8% | USD 49.181.8% | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,551,0590.7% | USD 58.140.7% | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,533,958-0.7% | USD 39.63-0.7% | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,517,128-0.9% | USD 9.32-0.9% | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,459,5661.9% | USD 49.751.9% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,446,0500.2% | USD 16.320.2% | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,377,466-2.6% | USD 43.8-2.6% | |
| GERN (Geron Corporation) | 324,203 | USD 1,335,716-1.2% | USD 4.12-1.2% | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,280,166-2.5% | USD 45.21-2.5% | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,239,7911.4% | USD 27.361.4% | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,208,3030.6% | USD 27.370.6% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,202,067-0.9% | USD 121.47-0.9% | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,193,69210.8% | USD 7.0710.8% | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,190,300-0.2% | USD 32.1-0.2% | |
| AMPH (Amphastar P) | 26,228 | USD 1,185,2430.0% | USD 45.190.0% | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,177,732-0.9% | USD 46.22-0.9% | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,162,479-1.4% | USD 57.74-1.4% | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,156,5481.8% | USD 20.041.8% | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,089,457-1.1% | USD 36.57-1.1% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,089,1531.0% | USD 45.151.0% | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,062,3753.2% | USD 52.453.2% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,059,573-1.8% | USD 33.15-1.8% | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,058,683-3.0% | USD 34.67-3.0% | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 1,022,2700.7% | USD 15.10.7% | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,017,915-2.3% | USD 21.05-2.3% | |
| MNKD (MannKind Corp) | 149,905 | USD 1,016,3562.6% | USD 6.782.6% | |
| ARVN (Arvinas Inc) | 36,691 | USD 980,3842.8% | USD 26.722.8% | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 912,468-0.4% | USD 12.86-0.4% | |
| XNCR (Xencor Inc) | 33,378 | USD 854,477-0.1% | USD 25.6-0.1% | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 850,9312.7% | USD 15.622.7% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 844,740 | USD 7.5 | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 821,315-1.7% | USD 9.89-1.7% | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 809,23611.4% | USD 13.0411.4% | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 796,2892.6% | USD 28.852.6% | |
| HROW (Harrow Health Inc) | 18,974 | USD 795,200-1.3% | USD 41.91-1.3% | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 793,0110.6% | USD 18.810.6% | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 789,664-0.1% | USD 16.27-0.1% | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 763,8344.1% | USD 22.114.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 761,8471.3% | USD 16.721.3% | |
| NVAX (Novavax Inc) | 85,838 | USD 748,5071.2% | USD 8.721.2% | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 746,946-0.1% | USD 14.51-0.1% | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 745,9101.5% | USD 13.931.5% | |
| ARDX (Ardelyx Inc) | 125,414 | USD 711,097-0.4% | USD 5.67-0.4% | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 700,3761.3% | USD 14.391.3% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 689,2810.1% | USD 8.859990.1% | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 681,680-0.3% | USD 32.74-0.3% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 678,8611.8% | USD 17.911.8% | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 647,729-3.6% | USD 57.23-3.6% | |
| INVA (Innoviva Inc) | 34,036 | USD 646,344-0.3% | USD 18.99-0.3% | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 614,912-4.1% | USD 24.38-4.1% | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 585,6651.3% | USD 7.961.3% | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 569,966-1.0% | USD 11.06-1.0% | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 558,170-0.7% | USD 9.50999-0.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 543,846-2.3% | USD 14.09-2.3% | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 535,184-0.7% | USD 30.5-0.7% | |
| REPL (Replimune Group Inc) | 36,624 | USD 515,6660.2% | USD 14.080.2% | |
| ETNB (89bio Inc) | 56,783 | USD 510,479-1.6% | USD 8.99-1.6% | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 490,8163.7% | USD 5.943.7% | |
| GRFS (Grifols SA ADR) | 69,287 | USD 484,316-13.4% | USD 6.99-13.4% | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 482,0520.3% | USD 3.010.3% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 480,130-1.1% | USD 22.08-1.1% | |
| GMAB (Genmab AS) | 22,228 | USD 477,9021.6% | USD 21.51.6% | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 464,1902.1% | USD 16.212.1% | |
| EOLS (Evolus Inc) | 33,552 | USD 459,327-0.8% | USD 13.69-0.8% | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 454,291-0.5% | USD 30.28-0.5% | |
| KURA (Kura Oncology Inc) | 40,849 | USD 450,973-1.2% | USD 11.04-1.2% | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 443,9182.0% | USD 13.82.0% | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 440,5144.8% | USD 9.459994.8% | |
| ERAS (Erasca Inc) | 151,442 | USD 433,124-2.1% | USD 2.86-2.1% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 430,262-4.2% | USD 5.67-4.2% | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 415,4572.8% | USD 13.452.8% | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 413,6691.6% | USD 16.911.6% | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 405,4300.2% | USD 20.40.2% | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 404,202-0.6% | USD 24.96-0.6% | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 377,9711.5% | USD 26.041.5% | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 374,6518.0% | USD 3.248.0% | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 367,033-0.7% | USD 9.90001-0.7% | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 354,7551.5% | USD 3.321.5% | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 349,799-0.3% | USD 3.46-0.3% | |
| CVAC (CureVac NV) | 121,688 | USD 349,245 | USD 2.87 | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 339,771-2.6% | USD 12.77-2.6% | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 336,036-2.1% | USD 4.7-2.1% | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 332,0189.0% | USD 2.789.0% | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 324,677-1.1% | USD 8.86999-1.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 303,387 | USD 10.12 | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 301,276-1.7% | USD 27.64-1.7% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 299,781-4.1% | USD 3.52-4.1% | |
| SVRA (Savara Inc) | 88,197 | USD 296,342-3.2% | USD 3.36-3.2% | |
| GRAL (GRAIL, LLC) | 16,644 | USD 291,2700.3% | USD 17.50.3% | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 289,6560.3% | USD 11.920.3% | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 288,363-2.7% | USD 12.76-2.7% | |
| HUMA (Humacyte Inc) | 63,797 | USD 288,3622.7% | USD 4.519992.7% | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 287,582-1.1% | USD 7.28-1.1% | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 286,5630.3% | USD 12.70.3% | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 280,7523.4% | USD 6.773.4% | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 277,324-0.8% | USD 2.48-0.8% | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 274,4408.5% | USD 1.918.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 266,0774.7% | USD 18.344.7% | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 265,133-0.9% | USD 23.37-0.9% | |
| RGNX (Regenxbio Inc) | 26,390 | USD 261,789-0.9% | USD 9.92001-0.9% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 255,473-2.2% | USD 8.85-2.2% | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 253,508-4.9% | USD 3.28-4.9% | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 252,366-0.4% | USD 4.55-0.4% | |
| OABI (OmniAb Inc.) | 63,047 | USD 246,5140.3% | USD 3.910.3% | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 242,655-2.9% | USD 5.61-2.9% | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 237,114-0.3% | USD 10.06-0.3% | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 234,053-1.8% | USD 9.25001-1.8% | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 225,396-3.4% | USD 3.94001-3.4% | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 217,058-0.4% | USD 7.83999-0.4% | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 211,517-0.3% | USD 3.28999-0.3% | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 209,25118.7% | USD 6.8600118.7% | |
| RVNC (Revance The) | 55,931 | USD 201,911-4.5% | USD 3.61-4.5% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 191,086-3.5% | USD 5.54001-3.5% | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 178,3530.1% | USD 8.550.1% | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 176,1432.9% | USD 1.782.9% | |
| ACIU (AC Immune Ltd) | 51,095 | USD 173,7231.2% | USD 3.41.2% | |
| SAGE (Sage Therapeutic) | 31,714 | USD 173,476-1.4% | USD 5.47001-1.4% | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 170,352-0.8% | USD 5.15001-0.8% | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 161,358-2.6% | USD 2.23999-2.6% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 155,511-0.1% | USD 0.803699-0.1% | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 146,667-1.2% | USD 3.42001-1.2% | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 146,5696.5% | USD 4.076.5% | |
| ALEC (Alector Inc) | 54,386 | USD 140,8601.8% | USD 2.591.8% | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 139,5943.1% | USD 7.239983.1% | |
| QURE (Uniqure NV) | 23,373 | USD 139,537-0.8% | USD 5.97001-0.8% | |
| PGEN (Precigen Inc) | 142,457 | USD 132,7842.5% | USD 0.9320992.5% | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 132,2882.7% | USD 0.9450972.7% | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 132,255-2.5% | USD 3.84999-2.5% | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 129,848-0.6% | USD 3.61-0.6% | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 113,7793.0% | USD 0.50673.0% | |
| MGNX (MacroGenics Inc) | 31,524 | USD 113,171-1.4% | USD 3.58999-1.4% | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 104,7561.1% | USD 2.681.1% | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 102,131-0.5% | USD 2.19001-0.5% | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 98,62126.9% | USD 3.8226.9% | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 94,0081.8% | USD 2.239991.8% | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 69,843-3.2% | USD 1.22001-3.2% | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 42,862-2.0% | USD 1.47999-2.0% | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 40,9602.7% | USD 1.139992.7% | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 39,0577.2% | USD 0.4057.2% | |
| ME (23Andme Holding Co) | 9,642 | USD 34,22913.1% | USD 3.5499913.1% | |
| OKUR (OKUR) | 2,188 | USD 33,7394.5% | USD 15.424.5% | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 22,0472.4% | USD 1.259972.4% | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 9,003-0.1% | USD 0.324608-0.1% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 89,361 | USD 41,513,546 | USD 464.56 | |
| AMGN (Amgen Inc) | 132,755 | USD 37,180,693 | USD 280.07 | |
| REGN (Regeneron Pharmaceuticals Inc) | 37,400 | USD 28,232,138 | USD 754.87 | |
| ALNY (Alnylam Pharmaceuticals Inc) | 68,980 | USD 17,502,985 | USD 253.74 | |
| BIIB (Biogen Inc) | 78,281 | USD 12,511,652 | USD 159.83 | |
| ILMN (Illumina Inc) | 85,626 | USD 12,360,969 | USD 144.36 | |
| ARGX (argenx NV ADR) | 17,240 | USD 10,595,532 | USD 614.59 | |
| UTHR (United Therapeutics Corporation) | 23,885 | USD 9,031,635 | USD 378.13 | |
| MRNA (Moderna Inc) | 206,666 | USD 8,967,238 | USD 43.39 | |
| VTRS (Viatris Inc) | 641,033 | USD 8,474,456 | USD 13.22 | |
| INCY (Incyte Corporation) | 103,680 | USD 7,822,656 | USD 75.45 | |
| SNY (Sanofi ADR) | 157,317 | USD 7,664,484 | USD 48.72 | |
| SMMT (Summit Therapeutics PLC) | 388,641 | USD 7,360,861 | USD 18.94 | |
| SRPT (Sarepta Therapeutics Inc) | 51,362 | USD 7,084,874 | USD 137.94 | |
| INSM (Insmed Inc) | 92,172 | USD 6,994,011 | USD 75.88 | |
| NBIX (Neurocrine Biosciences Inc) | 54,174 | USD 6,857,887 | USD 126.59 | |
| BMRN (Biomarin Pharmaceutical Inc) | 102,164 | USD 6,683,569 | USD 65.42 | |
| RPRX (Royalty Pharma Plc) | 240,364 | USD 6,393,682 | USD 26.6 | |
| BNTX (BioNTech SE) | 52,597 | USD 6,349,510 | USD 120.72 | |
| MEDP (Medpace Holdings Inc) | 16,697 | USD 5,659,615 | USD 338.96 | |
| PCVX (Vaxcyte Inc) | 60,123 | USD 5,650,360 | USD 93.98 | |
| EXEL (Exelixis Inc) | 153,010 | USD 5,497,649 | USD 35.93 | |
| RVMD (Revolution Medicines Inc) | 89,766 | USD 5,258,492 | USD 58.58 | |
| ROIV (Roivant Sciences Ltd) | 398,577 | USD 5,057,942 | USD 12.69 | |
| ITCI (Intracellular Th) | 56,633 | USD 4,903,851 | USD 86.59 | |
| BGNE (BeiGene Ltd) | 23,732 | USD 4,892,589 | USD 206.16 | |
| ASND (Ascendis Pharma AS) | 31,076 | USD 4,236,125 | USD 136.315 | |
| JAZZ (Jazz Pharmaceuticals PLC) | 33,122 | USD 4,062,082 | USD 122.64 | |
| MDGL (Madrigal Pharmaceuticals Inc) | 11,650 | USD 3,861,393 | USD 331.45 | |
| CYTK (Cytokinetics Inc) | 63,107 | USD 3,295,448 | USD 52.22 | |
| HALO (Halozyme Therapeutics Inc) | 67,954 | USD 3,293,730 | USD 48.47 | |
| BPMC (Blueprint Medicines Corp) | 33,972 | USD 3,230,737 | USD 95.1 | |
| NUVL (Nuvalent Inc) | 32,013 | USD 3,097,578 | USD 96.76 | |
| KRYS (Krystal Biotech Inc) | 15,463 | USD 3,044,819 | USD 196.91 | |
| IONS (Ionis Pharmaceuticals Inc) | 78,879 | USD 2,831,756 | USD 35.9 | |
| BBIO (BridgeBio Pharma Inc) | 101,463 | USD 2,789,218 | USD 27.49 | |
| ADMA (ADMA Biologics Inc) | 125,838 | USD 2,747,044 | USD 21.83 | |
| RNA (Avidity Biosciences Inc) | 62,822 | USD 2,722,077 | USD 43.33 | |
| ALKS (Alkermes Plc) | 88,318 | USD 2,589,484 | USD 29.32 | |
| ACLX (Arcellx Inc) | 29,004 | USD 2,583,386 | USD 89.07 | |
| AXSM (Axsome Therapeutics Inc) | 25,789 | USD 2,569,874 | USD 99.65 | |
| CRNX (Crinetics Pharmaceuticals Inc) | 42,935 | USD 2,476,061 | USD 57.67 | |
| RARE (Ultragenyx) | 49,439 | USD 2,379,499 | USD 48.13 | |
| CRSP (Crispr Therapeutics AG) | 46,108 | USD 2,344,131 | USD 50.84 | |
| GH (Guardant Health Inc) | 65,639 | USD 2,303,929 | USD 35.1 | |
| IMVT (Immunovant Inc) | 78,337 | USD 2,250,622 | USD 28.73 | |
| APLS (Apellis Pharmaceuticals Inc) | 65,103 | USD 2,222,616 | USD 34.14 | |
| RYTM (Rhythm Pharmaceuticals Inc) | 32,699 | USD 2,035,513 | USD 62.25 | |
| DNLI (Denali Therapeutics Inc) | 76,486 | USD 1,924,388 | USD 25.16 | |
| IBRX (Immunitybio Inc) | 375,676 | USD 1,915,948 | USD 5.1 | |
| LEGN (Legend Biotech Corp) | 43,819 | USD 1,889,913 | USD 43.13 | |
| PTCT (PTC Therapeutics Inc) | 41,134 | USD 1,855,555 | USD 45.11 | |
| AGIO (Agios Pharm) | 30,459 | USD 1,786,725 | USD 58.66 | |
| VCYT (Veracyte Inc) | 41,007 | USD 1,758,790 | USD 42.89 | |
| XENE (Xenon Pharmaceuticals Inc) | 40,483 | USD 1,746,841 | USD 43.15 | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 66,615 | USD 1,741,982 | USD 26.15 | |
| DYN (Dyne Therapeutics Inc) | 53,858 | USD 1,676,600 | USD 31.13 | |
| SWTX (SpringWorks Therapeutics Inc) | 39,738 | USD 1,658,267 | USD 41.73 | |
| MRUS (Merus BV) | 36,597 | USD 1,645,767 | USD 44.97 | |
| SRRK (Scholar Rock Holding Corp) | 42,777 | USD 1,631,943 | USD 38.15 | |
| EWTX (Edgewise Therapeutics Inc) | 50,414 | USD 1,623,331 | USD 32.2 | |
| KYMR (Kymera Therapeutics Inc) | 34,640 | USD 1,623,230 | USD 46.86 | |
| FOLD (Amicus Therapeutics Inc) | 158,843 | USD 1,582,076 | USD 9.96 | |
| VRNA (Verona Pharma PLC ADR) | 38,707 | USD 1,544,409 | USD 39.9 | |
| VCEL (Vericel Corp Ord) | 26,678 | USD 1,540,921 | USD 57.76 | |
| TWST (Twist Bioscience Corp) | 31,860 | USD 1,539,475 | USD 48.32 | |
| IOVA (Iovance Biotherapeutics Inc) | 162,782 | USD 1,530,151 | USD 9.4 | |
| ACAD (ACADIA Pharmaceuticals Inc) | 88,606 | USD 1,443,392 | USD 16.29 | |
| VERA (Vera Therapeutics Inc) | 29,338 | USD 1,432,575 | USD 48.83 | |
| PTGX (Protagonist Therapeutics Inc) | 31,449 | USD 1,413,633 | USD 44.95 | |
| GERN (Geron Corporation) | 324,203 | USD 1,351,927 | USD 4.17 | |
| JANX (Janux Therapeutics Inc) | 28,316 | USD 1,313,579 | USD 46.39 | |
| IDYA (Ideaya Biosciences Inc) | 45,314 | USD 1,223,025 | USD 26.99 | |
| LGND (Ligand Pharmaceuticals Incorporated) | 9,896 | USD 1,212,755 | USD 122.55 | |
| BEAM (Beam Therapeutics Inc) | 44,147 | USD 1,200,798 | USD 27.2 | |
| AKRO (Akero Therapeutics Inc) | 37,081 | USD 1,192,896 | USD 32.17 | |
| MIRM (Mirum Pharmaceuticals Inc) | 25,481 | USD 1,188,689 | USD 46.65 | |
| AMPH (Amphastar P) | 26,228 | USD 1,185,768 | USD 45.21 | |
| KROS (Keros Therapeutics Inc) | 20,133 | USD 1,178,787 | USD 58.55 | |
| NVCR (Novocure Ltd) | 57,712 | USD 1,136,349 | USD 19.69 | |
| SUPN (Supernus Pharmaceuticals Inc) | 29,791 | USD 1,101,969 | USD 36.99 | |
| HRMY (Harmony Biosciences Holdings) | 30,536 | USD 1,091,662 | USD 35.75 | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 31,963 | USD 1,078,751 | USD 33.75 | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 24,123 | USD 1,078,298 | USD 44.7 | |
| RXRX (Recursion Pharmaceuticals Inc) | 168,839 | USD 1,077,193 | USD 6.38 | |
| FTRE (Fortrea Holdings Inc.) | 48,357 | USD 1,042,093 | USD 21.55 | |
| TARS (Tarsus Pharmaceuticals Inc) | 20,255 | USD 1,029,764 | USD 50.84 | |
| WVE (Wave Life Sciences Ltd) | 67,700 | USD 1,014,823 | USD 14.99 | |
| MNKD (MannKind Corp) | 149,905 | USD 990,872 | USD 6.61 | |
| ARVN (Arvinas Inc) | 36,691 | USD 953,232 | USD 25.98 | |
| DVAX (Dynavax Technologies Corporation) | 70,954 | USD 916,016 | USD 12.91 | |
| XNCR (Xencor Inc) | 33,378 | USD 855,144 | USD 25.62 | |
| BCRX (BioCryst Pharmaceuticals Inc) | 112,632 | USD 844,740 | USD 7.5 | |
| OCUL (Ocular Therapeutix Inc) | 83,045 | USD 835,433 | USD 10.06 | |
| NTLA (Intellia Therapeutics Inc) | 54,477 | USD 828,595 | USD 15.21 | |
| HROW (Harrow Health Inc) | 18,974 | USD 805,826 | USD 42.47 | |
| MYGN (Myriad Genetics Inc) | 48,535 | USD 790,150 | USD 16.28 | |
| TVTX (Travere Therapeutics Inc) | 42,159 | USD 788,373 | USD 18.7 | |
| ZLAB (Zai Lab Ltd) | 27,601 | USD 776,416 | USD 28.13 | |
| SNDX (Syndax Pharmaceuticals Inc) | 45,565 | USD 752,278 | USD 16.51 | |
| SPRY (Silverback Therapeutics Inc) | 51,478 | USD 747,975 | USD 14.53 | |
| NVAX (Novavax Inc) | 85,838 | USD 739,924 | USD 8.62 | |
| DAWN (Day One Biopharmaceuticals Inc) | 53,547 | USD 734,665 | USD 13.72 | |
| NRIX (Nurix Therapeutics Inc) | 34,547 | USD 733,433 | USD 21.23 | |
| ARQT (Arcutis Biotherapeutics Inc) | 62,058 | USD 726,699 | USD 11.71 | |
| ARDX (Ardelyx Inc) | 125,414 | USD 713,606 | USD 5.69 | |
| RCKT (Rocket Pharmaceuticals Inc) | 48,671 | USD 691,128 | USD 14.2 | |
| AUPH (Aurinia Pharmaceuticals Inc) | 77,797 | USD 688,503 | USD 8.84999 | |
| IMCR (Immunocore Holdings Ltd) | 20,821 | USD 683,553 | USD 32.83 | |
| ANIP (ANI Pharmaceuticals Inc) | 11,318 | USD 672,176 | USD 59.39 | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 37,904 | USD 667,110 | USD 17.6 | |
| INVA (Innoviva Inc) | 34,036 | USD 648,386 | USD 19.05 | |
| ELVN (Enliven Therapeutics Inc.) | 25,222 | USD 640,891 | USD 25.41 | |
| VIR (Vir Biotechnology Inc) | 73,576 | USD 578,307 | USD 7.85999 | |
| AVDL (Avadel Pharmaceuticals PLC) | 51,534 | USD 575,635 | USD 11.17 | |
| COGT (Cogent Biosciences Inc) | 58,693 | USD 562,279 | USD 9.58 | |
| GRFS (Grifols SA ADR) | 69,287 | USD 559,146 | USD 8.07 | |
| ZYME (Zymeworks Inc. Common Stock) | 38,598 | USD 556,583 | USD 14.42 | |
| COLL (Collegium Pharmaceutical Inc) | 17,547 | USD 538,868 | USD 30.71 | |
| ETNB (89bio Inc) | 56,783 | USD 518,997 | USD 9.14001 | |
| REPL (Replimune Group Inc) | 36,624 | USD 514,567 | USD 14.05 | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 21,745 | USD 485,348 | USD 22.32 | |
| ABCL (Abcellera Biologics Inc) | 160,150 | USD 480,450 | USD 3 | |
| ADPT (Adaptive Biotechnologies Corp) | 82,629 | USD 473,464 | USD 5.73 | |
| GMAB (Genmab AS) | 22,228 | USD 470,344 | USD 21.16 | |
| EOLS (Evolus Inc) | 33,552 | USD 463,018 | USD 13.8 | |
| CSTL (Castle Biosciences Inc) | 15,003 | USD 456,691 | USD 30.44 | |
| KURA (Kura Oncology Inc) | 40,849 | USD 456,283 | USD 11.17 | |
| PRTA (Prothena Corporation plc) | 28,636 | USD 454,740 | USD 15.88 | |
| MRVI (Maravai Lifesciences Holdings Inc) | 75,884 | USD 449,233 | USD 5.92 | |
| ERAS (Erasca Inc) | 151,442 | USD 442,211 | USD 2.92 | |
| PLRX (Pliant Therapeutics Inc) | 32,168 | USD 435,233 | USD 13.53 | |
| AVXL (Anavex Life Sciences Corp) | 46,566 | USD 420,491 | USD 9.03 | |
| PCRX (Pacira BioSciences, Inc.) | 24,463 | USD 407,064 | USD 16.64 | |
| ANAB (AnaptysBio Inc) | 16,194 | USD 406,793 | USD 25.12 | |
| BCYC (Bicycle Therapeutics Ltd) | 19,874 | USD 404,436 | USD 20.35 | |
| CGEM (Cullinan Oncology LLC) | 30,889 | USD 404,337 | USD 13.09 | |
| TRML (Tourmaline Bio Inc.) | 14,515 | USD 372,455 | USD 25.66 | |
| ORIC (Oric Pharmaceuticals Inc) | 37,074 | USD 369,628 | USD 9.97001 | |
| ABUS (Arbutus Biopharma Corp) | 101,098 | USD 350,810 | USD 3.47 | |
| AUTL (Autolus Therapeutics Ltd) | 106,854 | USD 349,413 | USD 3.27 | |
| CVAC (CureVac NV) | 121,688 | USD 349,245 | USD 2.87 | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 26,607 | USD 348,818 | USD 13.11 | |
| TSHA (Taysha Gene Therapies Inc) | 115,633 | USD 346,899 | USD 3 | |
| RLAY (Relay Therapeutics Inc) | 71,497 | USD 343,186 | USD 4.80001 | |
| PHAT (Phathom Pharmaceuticals Inc) | 36,604 | USD 328,338 | USD 8.97 | |
| IRWD (Ironwood Pharmaceuticals Inc) | 85,165 | USD 312,556 | USD 3.67001 | |
| GLPG (Galapagos NV ADR) | 10,900 | USD 306,508 | USD 28.12 | |
| SVRA (Savara Inc) | 88,197 | USD 306,044 | USD 3.47 | |
| SANA (Sana Biotechnology Inc) | 119,431 | USD 304,549 | USD 2.55 | |
| OLMA (Olema Pharmaceuticals Inc) | 29,979 | USD 303,387 | USD 10.12 | |
| THRD (Third Harmonic Bio Inc.) | 22,599 | USD 296,273 | USD 13.11 | |
| SIGA (SIGA Technologies Inc) | 39,503 | USD 290,742 | USD 7.36 | |
| GRAL (GRAIL, LLC) | 16,644 | USD 290,438 | USD 17.45 | |
| YMAB (Y mAbs Therapeutics) | 24,300 | USD 288,684 | USD 11.88 | |
| URGN (UroGen Pharma Ltd) | 22,564 | USD 285,660 | USD 12.66 | |
| HUMA (Humacyte Inc) | 63,797 | USD 280,707 | USD 4.4 | |
| ALLO (Allogene Therapeutics Inc) | 111,824 | USD 279,560 | USD 2.5 | |
| MGTX (MeiraGTx Holdings PLC) | 41,470 | USD 271,629 | USD 6.55001 | |
| PAHC (Phibro Animal Health Corporation) | 11,345 | USD 267,629 | USD 23.59 | |
| XERS (Xeris Pharmaceuticals Inc) | 77,289 | USD 266,647 | USD 3.45 | |
| RGNX (Regenxbio Inc) | 26,390 | USD 264,164 | USD 10.01 | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 28,867 | USD 261,246 | USD 9.04999 | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 14,508 | USD 254,035 | USD 17.51 | |
| SLRN (ACELYRIN, INC. Common Stock) | 55,465 | USD 253,475 | USD 4.57 | |
| PACB (Pacific Biosciences of California) | 143,686 | USD 252,887 | USD 1.76 | |
| VERV (Verve Therapeutics Inc) | 43,254 | USD 250,008 | USD 5.78 | |
| OABI (OmniAb Inc.) | 63,047 | USD 245,883 | USD 3.9 | |
| TBPH (Theravance Biopharma Inc) | 25,303 | USD 238,354 | USD 9.41999 | |
| KALV (Kalvista Pharmaceuticals Inc) | 23,570 | USD 237,821 | USD 10.09 | |
| TNGX (Tango Therapeutics Inc) | 57,207 | USD 233,405 | USD 4.08001 | |
| FDMT (4D Molecular Therapeutics Inc) | 27,686 | USD 217,889 | USD 7.87001 | |
| PRME (Prime Medicine, Inc. Common Stock) | 64,291 | USD 212,160 | USD 3.3 | |
| RVNC (Revance The) | 55,931 | USD 211,419 | USD 3.78 | |
| AMLX (Amylyx Pharmaceuticals Inc) | 34,492 | USD 197,984 | USD 5.74 | |
| ITOS (Iteos Therapeutics Inc) | 20,860 | USD 178,144 | USD 8.53998 | |
| VYGR (Voyager Therapeutics Inc) | 30,503 | USD 176,307 | USD 5.77999 | |
| SAGE (Sage Therapeutic) | 31,714 | USD 176,013 | USD 5.55001 | |
| ACIU (AC Immune Ltd) | 51,095 | USD 171,679 | USD 3.36 | |
| VNDA (Vanda Pharmaceuticals Inc) | 33,078 | USD 171,675 | USD 5.19001 | |
| ATAI (ATAI Life Sciences BV) | 98,957 | USD 171,196 | USD 1.73 | |
| NAUT (Nautilus Biotechnology Inc) | 72,035 | USD 165,681 | USD 2.30001 | |
| LXRX (Lexicon Pharmaceuticals Inc) | 193,494 | USD 155,743 | USD 0.804898 | |
| AVIR (Atea Pharmaceuticals Inc) | 42,885 | USD 148,382 | USD 3.46 | |
| QURE (Uniqure NV) | 23,373 | USD 140,705 | USD 6.01998 | |
| ALEC (Alector Inc) | 54,386 | USD 138,412 | USD 2.54499 | |
| ACRS (Aclaris Therapeutics Inc) | 36,012 | USD 137,566 | USD 3.82 | |
| FULC (Fulcrum Therapeutics Inc) | 34,352 | USD 135,690 | USD 3.94999 | |
| BMEA (Biomea Fusion Inc) | 19,281 | USD 135,353 | USD 7.02002 | |
| ZNTL (Zentalis Pharmaceuticals Llc) | 35,969 | USD 130,567 | USD 3.62999 | |
| PGEN (Precigen Inc) | 142,457 | USD 129,550 | USD 0.909397 | |
| LYEL (Lyell Immunopharma Inc) | 139,973 | USD 128,845 | USD 0.920499 | |
| MGNX (MacroGenics Inc) | 31,524 | USD 114,747 | USD 3.63999 | |
| AMRN (Amarin Corporation PLC) | 224,549 | USD 110,478 | USD 0.492 | |
| VTYX (Ventyx Biosciences Inc) | 39,088 | USD 103,583 | USD 2.64999 | |
| CRBU (Caribou Biosciences Inc) | 46,635 | USD 102,597 | USD 2.2 | |
| EDIT (Editas Medicine Inc) | 41,968 | USD 92,330 | USD 2.20001 | |
| CABA (Cabaletta Bio Inc) | 25,817 | USD 77,709 | USD 3.00999 | |
| CHRS (Coherus BioSciences Inc) | 57,248 | USD 72,132 | USD 1.25999 | |
| ALXO (Alx Oncology Holdings ) | 28,961 | USD 43,731 | USD 1.51 | |
| OVID (Ovid Therapeutics Inc) | 35,930 | USD 39,882 | USD 1.10999 | |
| BLUE (Bluebird bio Inc) | 96,437 | USD 36,434 | USD 0.377801 | |
| OKUR (OKUR) | 2,188 | USD 32,295 | USD 14.7601 | |
| ME (23Andme Holding Co) | 9,642 | USD 30,276 | USD 3.14001 | |
| RAPT (RAPT Therapeutics Inc) | 17,498 | USD 21,523 | USD 1.23003 | |
| MRNS (Marinus Pharmaceuticals Inc) | 27,735 | USD 9,008 | USD 0.324788 | |